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Abstract 
 
Beta-alanine supplementation has been shown to increase skeletal muscle carnosine 
concentration resulting in the delay of neuromuscular fatigue and an increased aerobic and 
anaerobic capacity.  The current study investigated the effects of beta-alanine supplementation on 
aerobic and anaerobic capacity in trained cyclists.  Fourteen highly-competitive (sprint, 
endurance, road and track) cyclists underwent an 8 week 6.4g/day protocol (beta-alanine and 
maltodextrin).  Pre and post supplementation testing included a VO2max test (familiarization and 
characterization), maximum aerobic power test (aerobic capacity), and 30s wingate anaerobic test 
(anaerobic capacity).  Aerobic capacity parameter measures included aerobic and anaerobic 
thresholds, and maximum aerobic power, while anaerobic capacity parameters included fatigue 
index, average power, peak power, watts per kilogram, and final lactate concentration. 
 
There was a lack of change in aerobic and anaerobic capacity parameters post supplementation 
for both groups.  Assuming an increase in skeletal muscle carnosine concentration, results 
suggest 8 weeks 6.4g/day beta-alanine does not increase aerobic and anaerobic capacity in trained 
cyclists.  This lack of change has 3 potential explanations; carnosines’ physicochemical H+ 
buffering ability was not substantially elevated to prevent muscular fatigue via acidosis, pH 
decrease is only one limiting factor in aerobic and anaerobic capacity, or other factors 
(neuromuscular junction failure, contractile failure, substrate depletion, metabolite accumulation, 
oxidative stress) influence muscular fatigue. 
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CHAPTER ONE 
Introduction 
Performance 
Striving for excellence in sport is achieved in several ways; naturally, through training and 
adaptation, artificially, through the use of performance enhancing drugs/supplements, and most 
importantly, genetics.  Such an example of artificial enhancement is the East German regime of 
the 1970s, where in the need to succeed, hormone doping became a natural part of the training 
regime and led not only to extraordinary adaptation, but to a substantial improvement in 
performance (Franke and Berendonk, 1997).  Performance enhancing supplementation is a 
common tool for pushing the boundaries of human physiological development.  In the body-
building world where bigger is better, it is common practice to abuse the wide variety of 
synthetic hormones available in today’s market (Jazayeri and Amani, 2004) that act on muscle 
hypertrophy stimulation (increase muscle protein synthesis and anabolism) (Kadi et al., 1999).  
This brought about the development of the World Anti Doping Agency (WADA) who have not 
only established a prohibited list of substances, but developed testing procedures to combat such 
use. 
 
Natural performance enhancement, although not as dramatic and effective, comes through the 
means of training adaptation and mental preparation.  Adaptation requires stressing the 
physiological system into an unaccustomed state.  With the appropriate rest, adaptation of the 
body (heal) to the new stress will result in an increase in performance/capacity (Radak et al., 
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2001).  A question posed by athletes, coaches and scientists is whether legal sports supplements 
can help improve aerobic/anaerobic performance/capacity associated with sporting success. 
 
Cycling Disciplines 
Cycling (road, track, and mountain) includes a range of anaerobic (track sprint) and aerobic 
events (road race).  Each discipline requires specific training to achieve optimal performance 
(Table 1).  For example, the Tour de France, the event most commonly associated with cycling, 
covers approximately 3500km and is dominated by aerobic capacity and lactate threshold 
(Kenefick et al., 2002, Lucía et al., 2003).  In comparison, several disciplines are track based and 
more commonly associated with power, dominated by riders with large quadriceps, explosive 
high power outputs, and a heavily developed anaerobic system.  Events of this nature include the 
match sprint, keirin, and the kilometer time trial (kilo).  The match sprint suits riders with 
explosive power, size, and strength over 5-10s (Dorel et al., 2005), while the keirin and kilo are 
governed by the ability to maintain the same power for a sustained duration (30-65s).  Thus, in 
order to succeed at such events, a tolerance to pain is a necessity (muscular acidosis).   
 
The scratch race, points race, Madison, teams pursuit, and individual pursuit however, are 
typically based upon aerobic capacity (Schumacher and Mueller, 2002), a high lactate threshold, 
periods of explosive power, and an ability to recover from numerous anaerobic efforts.  What is 
thought to govern success in these events is the ability to manage and control lactate 
concentrations. 
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Table 1. The type, duration and training associated with the cycling disciplines. (Based on the 
programs of the current New Zealand sprint and endurance squads, 2010) 
Event Duration of event Training Zones 
Road race 2-7 hours Aerobic (2-7 hours), 
VO2max 
and lactate threshold 
(LT) training 
 
Road time trial 
 
50-65 minutes 
 
Aerobic, VO2max and 
LT training 
 
Scratch 
 
15-25 minutes 
 
Aerobic, LT and 
sprint training 
 
Points/Madison 
 
20-30 minutes 
 
Aerobic, LT and 
sprint training 
 
Pursuit 
 
3:30-4:30 minutes 
 
Aerobic, LT and LTol 
training 
 
Kilo/Keirin 
 
 
30-65 seconds 
 
Aerobic, LTol, 
VO2max and sprint 
training 
 
Sprint 
 
10-20 seconds 
 
Aerobic, LTol, and 
sprint training 
 
 
A cyclist’s control of threshold, characterized by the highest intensity at which lactate production 
and elimination are in equilibrium (Faude et al., 2009) (main determinant in road cycling 
success), and/or tolerance to lactate is an important aspect to success.  Lactate production, and 
therefore H+ production (decreases muscle pH and therefore muscle activation), is an aspect of 
fatigue that determines cycling performance (Messonnier et al., 2007).    Lactate control has 2 
aspects: lactate management, where managing levels of lactate above and below the threshold 
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determines the outcome in pursuit and time trial events, and lactate tolerance, where the 
production is not the determinant of performance, but rather the athlete’s tolerance to the 
increasing lactate concentration (pain) (success in events like the keirin and kilo). It is therefore 
important that the cycling fraternity receive unbiased, independent advice regarding the control of 
acidosis toward aerobic and anaerobic metabolism/capacity.   
 
Energy Systems 
Cycling is sustained through the aerobic and anaerobic metabolic energy systems that provide 
chemical energy in the form of adenosine triphosphate (ATP).  Initially, all cycling events utilize 
the readily available store of ATP within the muscle.  Following depletion, specific events utilize 
specific pathways to produce the required energy for muscle contraction.  For explosive events 
(sprint and keirin), the ATP-PC energy system is employed to provide rapidly utilizable ATP 
(Wells et al., 2009) during high intensity exercise such as track sprint cycling (Flyger, 2008).  
Through the chemical breakdown of phosphocreatine (PCr) (a phosphorylated creatine molecule 
that serves as a rapidly mobilizable reserve of high energy phosphates used to form ATP from 
ADP during the first 2-8 seconds (Karlsson and Saltin, 1970) of intense exercise) a phosphate 
group is liberated and provided to ADP.  The creatine molecule itself is formed from arginine, 
methionine and glycine through a series of catalyzed chemical reactions (creatine kinases) in the 
liver, kidneys, and pancreas (Williams and Branch, 1998) and transported via the bloodstream to 
the skeletal muscle (Walker, 1979).  Creatine concentration within striated human muscle is 
approximately 4µmol g-1 (Clark, 1997), with evidence indicating this concentration can increase 
following supplementation and extend the duration of the ATP-PC system (Birch et al., 1994).  
Following PCr consumption, activation of the anaerobic metabolic pathway (fast-rate glycolysis) 
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occurs.  The production of ATP sustains muscle contraction for events of 2 minutes or less (kilo) 
(Robergs et al., 2004) and is discussed shortly.   
 
Fast rate glycolysis is heavily relied upon in the keirin and kilo (2 minutes or less), and to a lesser 
extent in the scratch and points race.  Through the breakdown of glycogen to glucose in the 
absence of oxygen, and the subsequent enzymatic reactions to produce pyruvate and lactic acid 
(glycolysis) enough ATP is created to provide chemical energy for muscle contraction (Gastin, 
2001).  Muscular acidosis (decrease in muscle pH) arises due to the automatic dissociation of 
lactic acid at neutral pH (lactate (La-) and hydrogen (H+) ion) (Cooke et al., 1988, and Lamb et 
al., 1992).  At low pH, it remains in its undissociated form (lactic acid pKa 3.86 (Graves et al., 
2006)), however under physiological conditions (7.4), dissociation into the ion salt occurs.  The 
consequent drop in pH alters muscle mechanics, resulting in fatigue and decreased performance.  
If, however, sustained muscular contractions are required (road and pursuit events), the oxidative 
phosphorylation pathway provides an indefinite sustainable supply of ATP and is described in the 
following paragraph. 
 
The aerobic system (Ebert et al., 2006) is composed of three stages and is heavily relied upon in 
almost all disciplines of cycling.  Digestion is followed by the first stage incorporating glycolysis 
(carbohydrate breakdown) which breaks down glucose through a series of 10 enzyme catalyzed 
reactions to yield 2 ATP molecules, 2 molecules of NADH, and 2 molecules of pyruvate (Garret 
and Grisham, 2005), beta-oxidation, which breaks down fats in the mitochondria to acetyl-CoA, 
the entry molecule into the citric acid cycle, and deamination, which breaks down proteins in the 
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liver through amine group removal (deaminases).  In the presence of oxygen, slow rate glycoysis 
is utilized and the pyruvate molecules are fed into the second stage (Kreb’s cycle), where 1 ATP 
molecule, 1 carbon dioxide molecule, 3 NADH molecules, and 1 FADH molecule are produced 
per pyruvate molecule (Garret and Grisham, 2005).  Further progression of the NADH and 
FADH molecules into the electron transport chain (third stage) yields a total of 10 NADH+ 
molecules and 2 FADH+ molecules, which equates to 34 ATP molecules (Garret and Grisham, 
2005).  The production of 38 ATP molecules per molecule of glucose provides enough 
sustainable energy for muscular contraction during cycling events of long duration (road). 
 
In my study, progressive acidosis during cycling activity is under investigation with beta-alanine 
supplementation and cycling capacity.  The following section combines the structure and 
composition of skeletal muscle (which utilizes the production of chemical energy) in relation to 
cycling performance. 
 
Muscle Physiology 
Muscle physiology genetics is one determinant of cycling success.  Muscle composition (fibre 
type) pre-determines event specificity of an individual, so following is a discussion of the various 
aspects of muscle composition and structure in relation to cycling performance.  
 
Skeletal muscles are dominated by the presence of numerous myofibrils, each consisting of a 
highly regulated arrangement of cytoskeletal elements of thick (12-18nm assemblies of myosin) 
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and thin (5-8nm assemblies of actin) filaments, which combined make up the contractile region 
of the muscle (sarcomere) (Sherwood et al., 2005).   
 
Neural stimulation governs muscle contraction (Lomo, 2009), and release of acetyl choline 
(ACh) at the neuromuscular junction (between the motor neuron terminal and the muscle fibre) 
was identified as the key initiation step (Brown et al., 1936).  Subsequent post-synaptic binding 
of the molecule stimulates an action potential that is propagated across the entirety of the muscle 
cell membrane (Axelsson and Thesleff, 1959; Katz, 1961).  A propagated release of calcium ions 
(Ca2+) from the sarcoplasmic reticulum follows (SR, modified endoplasmic reticulum consisting 
of fine interconnected tubules surrounding the myofibrils) (Sherwood et al., 2005) when the 
action potential reaches the transverse tubules (T-tubules) which run primarily into the central 
portions of the muscle fibre.  The propagated release is achieved through the ryanodine calcium 
channels that are activated through coupling with dihydropyridine proteins (Bellinger et al., 
2009), with structural and/or functional defects of this channel causing dystrophic muscle 
(Bellinger et al., 2009).  The molecular regulation of the contraction couples the binding and 
dissociation of Ca2+ on troponin (Tn) to the movement of tropomyosin (Lehman et al., 2009) on 
the actin filaments exposing the actin binding sites allowing the formation of a cross-bridge 
(Craig and Lehman, 2001).  Activation of the “power stroke” (pulling of the actin filament) 
through the chemical energy supplied from ATP causes the muscle to contract (Geeves and 
Holmes, 1999).  Cytoplasmic Ca2+ is actively absorbed into the SR (SR Ca2+-ATPase pump) 
(Toyoshima, 2007) following the completion of the action potential, resulting in muscle 
relaxation, with a further ATP molecule liberating the cross bridge. 
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Cycling success is determined through the rate, durability, and susceptibility of muscle fibres to 
fatigue.  The 3 muscle fibre types can be distinguished by rate and force of contraction 
(Westerblad et al., 2010); slow-oxidative (type I), fast-oxidative (type IIa), and fast glycolytic 
(IIx) cover the fibre distribution among human skeletal muscles.  Depending on the training, type 
IIc, an undifferentiated fibre, has shown an ability to convert to either of the type II fibres (Staron 
et al., 1990).  Endurance events (such as road or pursuit) predominantly utilize type I and 
occasionally type IIa fibres (Greig and Jones, 2010), whereas the anaerobic power events (match 
sprint) predominantly utilize type IIx fibres.  Table 2 differentiates between fibre types based on 
rate of contraction and durability.   
 
Oxidative phosphorylation is the dominant metabolic pathway associated with type I fibres, 
whereas type IIa fibres rely on both mechanisms to produce ATP.  Minimal contractile activity in 
the absence of oxygen makes them less susceptible to the accumulation hypothesis (discussed in 
following section) and therefore predominantly used during road and aerobic track cycling 
events.  This is in accordance with a study in 2004 (Wang et al.) where mice genetically 
enhanced through activation of a form of peroxisome proliferator-activated receptor δ (PPARδ) 
in skeletal muscle, allowed the mice to run twice the distance compared to that of a wild-type 
littermate through the increased numbers of type I muscle fibres. However, the glycolytic fibres 
(type IIx), due to their design and contractile ability in the absence of oxygen, are susceptible to 
fatigue (metabolite accumulation) but produce great force and high contractile rates (Sherwood et 
al., 2005), essential to success in sprint orientated events.  Knowledge of muscle fibre fatigue is 
essential (prolonging the maximal activity of each fibre), and the following section discusses how 
skeletal muscle fibres are affected. 
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Muscular Fatigue 
Fatigue is the reduction in force generating capacity of a muscle through neuromuscular junction 
failure, contractile failure, substrate depletion, metabolite accumulation and/or oxidative stress 
(Fig. 1) (Bigland-Ritchie and Woods, 2004).  Skeletal muscle contractile activity can be 
maintained indefinitely at low intensity, however maintaining anaerobic activity for extensive 
periods is impossible. As fatigue materializes, muscle fibre tension declines, decreasing cycling 
performance. 
 
Table 2. Characteristics of skeletal muscle fibres.  (Adapted from Sherwood et al., 2005) 
 
Characteristic 
 
Type I 
Type of Fibre 
Type IIa 
 
 
Type IIx 
Myosin ATP-ase  
Activity 
Low High High 
 
Speed of  
contraction 
 
Slow 
 
Fast 
 
Fast 
 
Resistance to 
Fatigue 
 
High 
 
Intermediate 
 
Low  
 
Oxidative  
phosphorylation 
capacity 
 
High 
 
Intermediate 
 
Low 
 
Enzymes for 
anaerobic  
glycolysis 
 
Low 
 
Intermediate 
 
High 
 
Mitochondria 
 
Many 
 
Many 
 
Few 
 
Contraction rate 
 
Low 
 
Intermediate 
 
High 
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Muscular fatigue is thought to occur through several mechanisms (Fig. 1).  Inhibition of the axon 
terminal (Taylor et al., 2000), depletion of ACh, and altered neurotransmitter receptor binding 
(Luckin et al., 1991), result in fatigue of the neuromuscular junction (NMJ).  Contractile muscle 
failure (decreased force and rate) however, is based upon altered Ca2+ release and absorption 
from the SR.  These include an inability to release Ca2+ from the SR, an inability to absorb the 
Ca2+ following reduction of an action potential (Favero, 1999; and Rubtsov, 2001; Westerblad et 
al., 1991), and/or the inability of Ca2+/troponin binding and the formation of a cross bridge (Fitts, 
1994). 
 
The 2 primary hypotheses commonly associated with muscular fatigue are the depletion 
(exhaustion) and accumulation hypotheses first characterized in 1989 (McClaren et al.).  
Depletion of key metabolites (PCr, glycogen and ATP) (McClaren et al., 1989) characterize the 
depletion hypothesis, more commonly associated with the oxidative fibres and endurance events 
(road and pursuit).  The accumulation of metabolic by-products that interrupt the contractile 
mechanics of the skeletal muscle (lactate, inorganic phosphate (Pi), ADP, inosine monophosphate 
(IMP), ammonia (NH3), magnesium (Mg2+) and H+ ions) (McClaren et al., 1989) characterize the 
accumulation hypothesis, more commonly associated with the glycolytic fibres. 
 
Molecules identified in relation to the accumulation hypothesis are lactate ions (La-), H+, ADP, 
Pi, IMP, NH3, Mg2+, and inorganic phosphate (PO4-).  The high-energy splitting of PCr and ATP 
during cross-bridge formation (Robergs et al., 2004) produces an excess toxic level of PO4- that 
contributes to muscular fatigue (Westerblad et al., 2002).   This action mechanism prevents the 
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release of Ca2+ from the SR (Allen and Westerblad, 2001), and a low to high force transition rate 
of the contractile elements (diminishing force production) (Westerblad et al., 2002). 
 
 
 
Figure 1. Factors contributing to muscular fatigue (adapted from Begum et al., 2005) 
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ADP, also the result of the high energy splitting of ATP, in conjunction with Mg2+ (MgADP), has 
been shown to decrease maximum muscle fibre velocity and increase muscle isometric tension 
(Cooke and Pate, 1985).  While ADP and Mg2+ affect muscle fibre tension and velocity, IMP and 
NH3 (correlation in concentration with ADP, adenosine monophosphate (AMP), and depletion of 
PCr) (Sahlin et al., 1990), have been shown to decrease muscular force during continuous 
isometric contractions, reduce Mg2+-stimulated acto-myosin-ATPase activity (up to 60% at 10 
mM IMP), and prevent the formation of the actin-myosin complex (Westra et al., 2001).  This 
accumulation is thought to prevent an “energy crisis” during exhaustive exercise, by down 
regulating the contractile machinery (Westra et al., 2001). 
 
Excess lactic acid is produced during anaerobic metabolism (fast-rate glycolysis) (Marcinek et 
al., 2010), which further dissociates into the lactate (La-) and H+ (Brooks, 1986) at neutral pH (7-
7.4).  Increased La- concentration plays a minor, albeit significant role in muscular fatigue 
through interference with cross-bridge formation (Hogan et al., 1995).  Metabolic acidosis arises 
when H+ production exceeds the chemical and physiological mechanisms available to buffer it 
(Robergs et al., 2004).  In relation to lactate production, questions have been raised about the 
effect of H+ in relation to metabolic acidosis at physiological pH.  A direct correlation between 
lactate production and H+ accumulation has been identified (Marcinek et al., 2010), which 
suggests during intense exercise, concentrations will be similar.  A decrease in ATP production 
directly linked to enzyme structural changes, structural changes to membrane transport 
mechanisms, and changes to substrate availability (Robergs et al., 2004) identifies how important 
it is to manage lactate and H+ levels (an accumulation of lactate and H+ is correlated to a drop in 
ATP) .  Phosphofructokinase (PFK) (the rate-limiting enzyme in glycolysis) is a significant 
example, as the rate of reaction decreases following H+ ion adherence.  Subsequent reactions of 
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glycolysis fail to occur because of the alteration to the conformation of the enzyme, and the 
subsequent failure of its substrate (D-Fructose-6-phosphate) to recognize its binding site. 
 
The fundamental mechanics of muscle contraction are disrupted through the production of excess 
H+.  Inhibition of actomyosin ATPase (solely responsible for the breakdown of ATP and cross-
bridge formation (Cooke et al., 1988), and relaxation), interference with Ca2+ release, absorption 
from the SR (Lamb et al., 1992), and alterations to calcium-troponin binding are a result of 
increased H+ ion concentration.  In association with metabolite accumulation, a combination of 
these problems has shown to result in decreased force and rate of contraction in skeletal muscle.  
Therefore, it is imperative to delay fatigue, naturally or artificially, to improve 
capacity/performance. 
 
Natural Fatigue Controlling Mechanisms 
There are a range of natural fatigue controlling mechanisms available to delay the onset of 
muscular fatigue.  The human body is dependent on several biochemical pathways to alleviate 
increased levels of toxic products (accumulation hypothesis) and/or the depletion of key 
metabolites (depletion hypothesis). 
 
The issue during anaerobic metabolism is the accumulation of toxic metabolites and metabolic 
by-products.  First shown in 1953 (Harris), thwarting the detrimental effects of PO4- (ATP and 
PCr splitting) becomes increasingly difficult due to the muscle membrane having little or no 
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direct permeability to phosphate.  Transportation of phosphate ions out of a cell via a Na+ 
transporter is conceivable, with evidence showing a high concentration of phosphatase at the 
surface of secreting cells (Danielli, 1951).  In conjunction, the control of La- and H+ ion 
accumulation during anaerobic metabolism becomes crucial to muscle function.  Naturally 
buffering H+ is accomplished in part through sodium bicarbonate, with evidence showing a direct 
correlation between rising levels of lactate and decreasing levels of the compound (Beaver et al., 
1986). 
 
In conjunction with sodium bicarbonate, limiting the decrease in pH and accumulation of H+ in 
supramaximal exercise is accomplished through the function of the Na+/H+ exchanger, carbonic 
anhydrase (CA) enzymes (CA, CAII, CAIII, CAIV, CAXIV), and the monocarboxylate 
transporters (MCTI and MCT4) (Messonier et al., 2007).  Additionally, the evolution of an intra-
cellular non-bicarbonate proton buffering system aids skeletal muscle buffering abilities.  The 
imidazole rings found in histidine containing compounds (Abe, 2000) maintains a neutral pH, 
made possible through protonation of these compounds due to their pKa being closely associated 
with the intracellular pH of the cell (Abe, 2000). 
 
The body’s natural mechanisms can be enhanced by the use of substances/supplements that 
provide the athlete with a much greater resistance to fatigue than can be accomplished naturally 
(due to the demands of professional sport, and the drive to succeed).  In the following section, 
analysis of several illegal and legal compounds will be covered. 
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Ergogenic Aids – Cycling and Supplements 
It is becoming increasingly important to develop advanced mechanisms of fatigue resistance that 
allow individuals to compete at the highest level and succeed.  Millions of dollars worth of 
research has developed several ergogenic aids, some legal and some illegal, to cope with the 
demand of performance enhancement. 
 
Anabolic steroids are common illegal ergogenic aids (Calfee and Fadale, 2006, and Juhn, 2003).  
Synthetic testosterone (made famous by Floyd Landis in the Tour de France), anadrol, and 
nandrolone are prime examples.  Their ability to mimic the effects of testosterone and 
dihydrotestosterone (increased cell protein synthesis and muscle anabolism through cortisol 
blockage (Sheffield-Moore, 2000)) draws significant attention to these compounds in a range of 
sports, from bodybuilding to cycling.  Other illegal ergogenic aids include erythropoietin (EPO), 
human growth hormone (HGH), and to a lesser extent, amphetamines (stimulants), and 
painkillers.   
 
EPO, a glycoprotein hormone produced primarily in the kidney and liver, stimulates the 
production of red blood cells (erythropoeisis) within the bone marrow (Mairbaurl, 1994).  There 
is substantial evidence to conclude that an intravenous injection of EPO enhances aerobic 
performance (Thomson et al., 2007), making it popular among endurance athletes.  Red blood 
cell proliferation eventuates, increasing oxygen delivery to the working muscle following 
administration.  More commonly associated with strength/power sports (weightlifting) (Saugy et 
al., 2006), HGH, a naturally occurring polypeptide hormone, is responsible for growth, cell 
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reproduction, cell regeneration, and muscular physique, a trait highly sought after in 
strength/power sports.  Amphetamines, however, are primarily used as a stimulant to increase 
awareness, concentration, alertness, energy, and self asteem through its actions as a 
psychostimulant by increasing monoamine and dopamine levels (Fleckenstein et al., 2007).  
Painkillers on the other hand, are used extensively to achieve analgesia, allowing an athlete to 
push their performance beyond their natural pain barrier (Tscholl et al., 2009). 
 
There is a fine line between the legality of compounds that have been shown to increase 
performance.  Legal compounds include beta-alanine, creatine, sodium bicarbonate, colostrum 
and caffeine.  Because of its ergogenic properties in repetitive anaerobic cycling sprints (Calfee 
and Fadale, 2006; Juhn, 2003), creatine is becoming one of the most commonly used legal 
supplements among cyclists.  Creatine’s use was developed to improve the availability of the 
compound within skeletal muscles during intense exercise.  Through increased creatine 
availability (supplementation of 4 weeks or more), ATP synthesis duration can be extended 
(Bemben et al., 2001; Nelson et al., 2000).  At the opposing end of the supplementation spectrum, 
sodium bicarbonate (discussed previously) is commonly orally administered ninety minutes prior 
to an event, increasing blood sodium bicarbonate concentrations substantially, offsetting the 
acidity produced in the muscles during intense exercise, and essentially leading to an increase in 
blood pH (McNaughton et al., 1999).  Colostrum, however, (a form of milk produced by the 
mammary glands containing immunoglobulins, cytokines and growth factors) has been shown to 
decrease recovery time and prevent sickness during peak performance (Buckley et al., 2002).  
Caffeine, one of the more popular legal performance enhancing supplements, has been shown to 
bind to the adenosine receptors as a competitive inhibitor, resulting in increased cognitive 
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function (process of thought) (Foskett et al., 2009) correlating to an increase in performance 
(Graham and Spriet, 1991).  Beta-alanine and carnosine’s performance enhancing capabilities 
will be discussed in the following sections. 
 
Carnosine 
There is extensive literature on the function and mechanism of carnosine.  This review will 
encompass its absorption, relation to muscular fatigue (specifically as a pH buffer), action as an 
antioxidant, and action as a skeletal muscle regulator, all of which relate to performance. 
 
Carnosine is a naturally occurring histidine containing dipeptide also known as β-alanyl-L-
histidine (Hill et al., 2007) (Fig. 2).  It is commonly found in muscle and nerve cells (Hill et al., 
2007) and has effects not only on muscular fatigue resistance, but also roles in quenching free 
radicals (Kurihara et al., 2009), enzyme regulation (Johnson and Aldstadt, 1984), and calcium 
regulation from the SR (Batrukova and Rubtsov, 1997).   Its buffering potential was first 
established in 1953 (Severin et al.) using isolated frog muscle, which showed that muscles in the 
presence of carnosine could accumulate excessive amounts of lactate without hindrance to 
function.  However, in its absence, considerable acidosis occurred, hindering contractile function.  
This is commonly known as the Severin Phenomenon. 
 
 
Carnosine Absorption 
Information about carnosine absorption is equivocal.  Oral administration of carnosine as a 
dietary supplement, or through foods rich in the dipeptide (beef, pork), have been shown to not 
increase skeletal muscle concentrations (Kraemer et al., 1995) due to degradation of the molecule 
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within the gastrointestinal tract (Gardener et al., 1991).  Furthermore, evidence has shown (Chan 
et al., 1994) that rats who were fed a semi-purified diet containing carnosine and/or α-tocopherol 
showed no increase in carnosine concentration in heart muscle when fed only carnosine, however 
in combination with α-tocopherol, a 1.5 fold increase was observed.  However, recent research 
(Maynard et al., 2001) has shown that an increase in dietary carnosine by as little as 1.8% over an 
8 week period is sufficient to increase the concentration of carnosine in the soleus and lateral 
gastrocnemius muscles of rats.   
 
Oral supplementation of carnosine’s constituents (beta-alanine or histidine) has identified 
significant increases in muscle concentration (Harris et al., 2006) through the process depicted in 
Figure 2.  Histidine dietary deficiency can result in a carnosine concentration decrease within 
skeletal muscles of rats (Tamaki et al., 1984), while beta-alanine supplementation significantly 
elevates carnosine’s concentration (Harris et al., 2006).  Short-term increases have been shown to 
dramatically decrease following supplementation cessation (Boldyrev and Severin, 1990).  As 
described by Baguet et al. (2009), carnosine washout (carnosinase, Fig. 2) takes on average 6-15 
weeks depending upon the exercise status of the individual (Gardener et al., 1991).  Based on the 
evidence presented, skeletal muscle carnosine concentration following oral carnosine 
supplementation is equivocal, although significant elevations are observed following histidine 
and beta-alanine supplementation.   
 
 
Carnosine and Muscle Buffering 
During high intensity exercise, skeletal muscle cells become saturated with lactate and H+ 
(Livingstone et al., 2001), causing the interruption of muscle function.  The effect of various pH 
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levels on the excitation-contraction-coupling mechanism (ECC) of muscle contraction were 
investigated (Lamb et al., 1992).  Initial depolarization elicited a large response at all pH levels 
(6-8), however the subsequent responses decreased as pH became more acidic. Following a 
decrease in pH (accomplished via H+ ion increments), poor operation of the Ca2+-ATPase pump 
and subsequent decrease in ECC are observed. 
 
The presence of the imidazole group (Fig. 2) found in carnosine (and other histidine based 
compounds, such as anserine) is thought to play an important role in muscle buffering capacity 
(Abe, 2000); however the percentage of total muscle buffering capacity has yet to be determined.  
It was suggested over the physiological pH range (7.1-6.5), carnosine had a 7% role (Mannion et 
al., 1992) in total muscle buffering (2.4 and 10.1 mmol H+ kg-1).  In combination with anserine, 
an estimated 40% of total muscle buffering may be covered (Davey, 1960).  If the percentages 
were as high as suggested, one could significantly increase muscular performance in type I and 
type II fibres, by increasing skeletal muscle carnosine concentration. 
 
During high intensity exercise, elevated carnosine concentrations have been shown to increase 
the skeletal muscle buffering capacity (Suzuki et al., 2001).  A direct correlation between 
superior sprint performance and buffering capacity were observed in a group with significant 
elevations in vastus lateralis type II muscle fibre carnosine concentration (Suzuki et al., 2001). 
Carnosine concentration is directly dependent upon muscle fibre type, highlighting the 
importance of its use in endurance and strength/power sports.  With twice the carnosine 
concentration in type II fibres compared to type I fibres (23.2 ± 17.8 and 10.5 ± 7.6 mmol kg-1 
dry weight, respectively) (Harris et al., 1998), it is suggested that there is a direct correlation 
between carnosine concentration and type II fibre H+ ion concentration during anaerobic exercise.  
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Furthermore, studies (Mannion et al., 1992) have shown an average carnosine concentration of 20 
± 4.7mmol.kg-1 in the type II fibres of the quadriceps femoris in humans, with further evidence 
suggesting sex plays a significant role (significantly higher concentration in the male population). 
 
 
 
Figure 2. Metabolism of carnosine (Begum et al., 2005) 
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Carnosine as an Anti-oxidant 
Besides its effective role as a muscle buffering agent in skeletal muscles, there is evidence to 
suggest that carnosine plays an effective and important role as an anti-oxidant, through its 
biological function of quenching singlet molecular oxygen, and scavenging hydroxyl and 
superoxide radicals (Gariballa and Sinclair, 1992; Kohen et al., 1988; Pavlov et al., 1993).  It is 
well established that muscle contraction increases oxidative metabolism and the level of 
oxidative stress associated with it (Ji, 1995).  Elevations in reactive oxygen species (ROS) levels 
may occur (Mastaloudis, 2001) through increased respiration and an increase in electron flow 
through the electron transport chain.  In conjunction, ROS levels may rise due to depletion of 
ATP pools, leading to a higher intracellular level of ADP which triggers catabolism of ADP, and 
converts xanthine dehydrogenase to the superoxide generating enzyme xanthine oxidase (Moller 
et al., 1996).  Furthermore, a decrease in pH may promote oxygen release from hemoglobin. 
(Ebbeling and Clarkson, 1989).   
 
An increase in ROS has been shown to interrupt the SR Ca2+-ATPase (Moreau et al., 1998).  The 
specifics of interruption were examined (Xu et al., 1997) on isolated SR containing the Ca2+-
ATPase.  Further analysis identified complete inhibition of the pump through the attack of the 
ATP binding site by hydroxyl radicals.   
 
Carnosine’s antioxidative properties have been investigated several times.  An investigation into 
the effect of carnosine’s antioxidative properties was conducted on senile cataracts (formed from 
lipid peroxidation) in dog eyes (Boldyrev et al., 1987).  Further peroxidation of the cataracts was 
prevented through the interaction of carnosine, both in vitro and in vivo, with the lipids 
commonly associated with the issue.  Furthermore, the minimum effective concentration of 
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carnosine required to inhibit lipid and protein oxidation was determined to be 2.5mM and 1mM 
respectively, observed through exposure of isolated rat muscle tissue to free radicals (Nagasawa 
et al., 2001).  Further demonstration (Kang et al., 2002; Kohen et al., 1988) identified other 
histidine derivatives (homocarnosine and anserine) having similar antioxidative properties 
(imidazole group) (Fig.2).  Therefore, during endurance based sport where the body produces 
excess ROS, increased skeletal muscle carnosine concentration may prevent the consequent 
damage associated with ROS and improve performance/capacity. 
 
 
Carnosine as a Skeletal Muscle Regulator 
As discussed previously, muscle contraction is dependent upon SR release and absorption of 
Ca2+.  Inhibition of Ca2+ release and/or absorption is achieved through the concentration increase 
in H+.  Prohibiting the alteration of the rynaodine receptor transport mechanisms is preventable 
through the identification of carnosine’s H+ absorption properties.  It is suggested however, that 
there is a carnosine binding site on the SR Ca2+ ryanodine transporter for rapidly inducing Ca2+ 
release (carnosine concentration dependent) (Batrukova and Rubtsov, 1997).  Increased isolated 
rat heart contractility has been observed when saturated in carnosine (Roberts and Zaloga, 2000), 
suggesting that during high intensity cycling, carnosine may induce Ca2+ release and delay 
fatigue. 
 
Further documentation has shown that a reduction in action potential propagation is experienced 
when there is a loss of K+ and Na+ potential during repeated muscular contractions (Fitts and 
Balog, 1996).   The effects of muscular fatigue on Na+ and K+ concentrations, as well as 
membrane potential, were investigated on isolated semitendinosus frog muscle (Fitts and Balog, 
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1996).  Alterations in the concentrations led to 3 possible mechanisms of muscle fatigue.  1. It 
completely blocked the propagation of the action potential; 2. It caused depolarization-induced 
inactivation of T-tubular charge movement; and 3. It caused a reduction in magnitude of the t-
tubular charge due to the lower action potential spike potential.   This phenomenon occurs 
through disturbance of the membrane potential in the T-tubules and subsequent Ca2+ release from 
the SR (Fitts and Balog, 1996).  Severin’s phenomenon was justified when carnosine’s 
introduction restored muscular function of a neuromuscular preparation under fatigue (Petukhov 
et al., 1976).  Further analysis indicated that neither synaptic processes nor contractile 
mechanisms were responsible for muscle contraction continuation, but rather carnosine’s ability 
(properties) to restore transmembrane potential depolarized by exhaustion (Begum et al., 2005). 
 
Carnosine analysis in relation to absorption, muscular fatigue, antioxidative properties, and 
skeletal muscle regulation, classify how important an increase in its concentration may be to 
cycling performance/capacity.  In the succeeding sections, a discussion of carnosine’s rate-
limiting constituent, beta-alanine, and what evidence there is to suggest that it improves athletic 
performance will be conducted. 
 
 
Beta-alanine 
Beta-alanine (3-aminopropionic acid) (Fig. 3) is a naturally occurring, non-essential beta amino 
acid that is obtained through foods rich in dipeptides, such as carnosine, anserine and balenine 
(commonly found in chicken, pork or beef). Specific β-amino, sodium, and chloride transporters 
(Bakardjiev and Bauer, 1994) are responsible for transport of the amino acid across the gut wall.  
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The body can also synthesize beta-alanine in the liver through catabolism of pyrimidine 
nucleotides. These are broken down into uracil and thymine, and further metabolized into beta-
alanine and B-aminoisobutyrate (Zöllner, 1982).   
 
Beta-alanine supplementation may indirectly increase muscular endurance through its 
physicochemical buffering ability of H+.  The H+ buffering ability of the di-peptide carnosine 
(beta-alanine and histidine) is responsible and was discussed in the previous section.  Several 
studies have investigated the effects of beta-alanine supplementation on skeletal muscle carnosine 
concentration and muscular fatigue.  The following section highlights experimental design 
(dosage and timeline), subject , and the effect of beta-alanine supplementation on carnosine 
concentration and performance. 
 
 
Figure 3. Structure of beta-alanine. 
 
Beta-alanine Supplementation on Skeletal Muscle Carnosine Concentration 
Beta-alanine is the rate-limiting constituent in the formation of carnosine.  The concentration in 
which is it produced, which fibre type produces the highest concentration, and which muscles 
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(depending upon the fibre type) produce the highest concentration may be a determinant of 
sporting success. 
 
There is a consensus that oral beta-alanine supplementation increases skeletal muscle carnosine 
concentration (Table 3).  Muscle carnosine concentrations are analysed via a non-invasive 
technique known as proton magnetic resonance spectroscopy (proton MRS).  However, several 
other studies (Dunnett et al., 1999, Harris et al., 2006, Hill et al., 2007, Kendrik et al. 2009)  have 
successfully utilized the use of a muscle biopsy (invasive) followed by analysis using high 
performance liquid chromatography (HPLC).   
 
To date, there has been no evidence of a “ceiling effect” on skeletal muscle carnosine 
concentrations (Derave et al., 2007), with significant elevations in carnosine concentration above 
basal level still being observed among individuals with an initial high concentration (12mmol kg-
1).  A very similar protocol (Baguet et al., 2009) investigated human skeletal muscle carnosine 
loading and washout and identified a mere 1.7% increase in the soleus muscle of the control 
group and a 39% increase in the beta-alanine group following supplementation.  Following on 
from a previous gastrocnemius study (Maynard et al., 2001), a smaller, but still significant 
elevation in carnosine concentration was recognized in the beta-alanine group (23% increase).  
Fast twitch muscles have a significantly higher carnosine concentration (due to a higher 
expression of beta-alanine transporters (Bakardjiev and Bauer, 1994)), carnosinase activity 
(Bakardjiev and Bauer, 2000), and/or carnosine synthase activity (Horinishi et al., 1978) than 
slow twitch muscles (soleus).  The increase however, was directed evenly among the two fibre 
types, which agrees with previous research (Hill et al., 2007) that fibre types respond equally 
within the same muscle.   
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Table 3. Pre and post carnosine concentrations following beta-alanine supplementation protocols 
on human skeletal muscle. 
Study Dosage 
(g/day) 
N Duration 
(weeks) 
 Carnosine 
concentration 
pre (mmol kg-1) 
Carnosine 
concentration 
post (mmol kg-1) 
Derave et al. 
2007 
2.4-4.8 15 5 7.76±1.36 11.39±1.38 
Baguet et al. 
2009 
2.4-4.8 20 6 5.63±0.94 7.83±1.74 
Hill et al. 2007 4.0-6.4 25 10 21.8±1.6 34.7±3.7 
 
 
The carnosine concentration distribution among the different muscle fibre types is of particular 
importance for sporting performance.  The glycolytic fibres that utilize the ATP-PC and 
anaerobic systems are responsible for producing the necessary power during a cycling sprint.  
However, evidence suggests that, regardless of fibre type, carnosine concentrations increase 
equally (Kendrik et al., 2009) among type I and type II fibres. 
  
There is significant evidence to suggest that beta-alanine supplementation increases carnosine 
synthesis within skeletal muscle fibres.  The distribution of this increase is controversial, with 
some studies lending evidence to an equal balance among fibre types for carnosine concentration 
increase, and others stating the glycolytic fibre increases are substantially higher.  Both scenarios 
are beneficial to endurance (type I) and strength/power (type II) sports. 
 
 
Performance, Capacity, and Physiological Mechanisms 
Until recently, the effect beta-alanine supplementation had on athletic performance was 
essentially ignored.  Only within the last decade has the effectiveness of this carnosine 
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concentration increase come to light.  It is important to relate the performance changes associated 
with an elevated carnosine concentration to trained individuals who utilize the substance 
substantially more than the sedentary population. 
 
In 2003, significant improvements in 4 minute cycling power (38 Watts) were observed (Harris et 
al.); it was further identified that this change was due to increased H+ buffering activity observed 
within the first minute of exercise.  Similar research (Baguet et al., 2009) identified the 
physiological changes associated with beta-alanine supplementation in high-intensity cycling.  
Results yielded significant results including a difference in pH change between the beta-alanine 
and control groups after 6 minutes of high intensity exercise (exercise-induced acidosis).  
Pulmonary gas exchange values (VO2, ventilation, and CO2 output) between the 2 groups were 
found to be non-significant, lending evidence to believe that beta-alanine has no effect on aerobic 
parameters.   
 
Beta-alanine supplementation has been shown to significantly improve peak power (11.4%) and 
mean average power (5%) after exhaustive exercise (110 minute cycle race (van Thienen et al., 
2009).  Indications suggest beta-alanine supplementation has a positive effect on the aerobic 
system, the anaerobic system, and the crossover effect (switching from one to the other) when it 
comes to exercise capacity.  The significance this has on the outcome of a cycle stage such as that 
of the Tour de France is promising, with approximately half the stages contested by a sprint 
finish.   
 
Beta-alanine supplementation in power/strength sports is becoming a frequent occurrence.  In 
combination with creatine, beta-alanine supplementation (CBA) has shown significant increases 
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in 1 repetition max (1-RM) squat strength and bench press (Hoffman et al., 2006). However, it 
has failed to improve a 20-jump test, and more importantly the anaerobic power measures from a 
wingate anaerobic test.  Results of this nature make it hard to believe that supplementation 
improves anaerobic power even though strength levels may increase.   
 
Once again, results following beta-alanine supplementation on anaerobic power measures are 
equivocal.  Significant differences in 300 shuttle (sprinting to and from cones) time and flexed 
arm-hang time between groups have been identified (Kern et al., 2010), while other results 
(Hoffman et al., 2008) using college football players had contradictory results.  Although no 
significant differences in peak power, mean power, and total work between groups have been 
observed, an insignificant trend (P=0.07) in fatigue rates occurred, suggesting there may be an 
increase in hydrogen buffering capacity.  Similarly, repeated isokinetic contractions of 30s for a 
maximum of 5 repetitions, showed significantly higher average torque  in the beta-alanine group, 
and more specifically in bouts 4 (6.1%) and 5 (3.8%) (Derave et al., 2007).  Further analysis of 
the knee extensors in question during a 45% maximum voluntary contraction (MVC) turned up 
insignificant results, suggesting isometrically at least, beta-alanine supplementation does not 
cause a performance effect.   
 
With respect to performance improvement, 400m running times have been shown to significantly 
decrease following beta-alanine supplementation.  However, these observations occurred in both 
groups, suggesting that the changes in gastrocnemius carnosine concentration did not correlate 
with decreases in 400m times (Derave et al., 2007).  With respect to cycling events, the keirin and 
kilo closely resemble 400m in terms of time to complete and metabolic energy system 
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requirements.  This evidence would suggest that beta-alanine supplementation would not elevate 
performance/capacity.   
 
The ability to repeat maximal sprints in cycling is essential for success (points and scratch races).  
Evidence has shown there is no significant improvement following beta-alanine supplementation 
on power output during repeated sprint activity (10x5s sprints separated by 45s recovery).  A lack 
of change for peak power, average power, fatigue rates, and blood lactate levels further indicates 
increased carnosine concentration does not increase power output during repeated sprint bouts, 
and thus would not aid in recovery (muscular fatigue) during the points or scratch races. 
 
Neuromuscular fatigue (NMF) is characterized by an increase in the electrical activity of working 
muscles over time.  It is a fatigue-induced increase in electromyographic amplitude as a result of 
progressive recruitment of additional motor units and/or an increase in the firing frequency of the 
active motor units (Moritani et al., 1993).  Based on this, a term known as PWCFT (physical 
working capacity at fatigue threshold) was developed (deVries et al., 1987; deVries et al., 1990), 
and is the basis for neuromuscular studies.  Therefore, it was postulated that because of the 
properties of carnosine, an increase in its skeletal muscular concentration may delay the onset of 
NMF. 
 
In relation to cycling, evidence (Stout et al., 2007) justified the use of beta-alanine toward 
improving ventilatory threshold (VT) (13.9%), and more importantly PWCFT (12.6%).  In terms 
of VO2max and time to exhaustion, no significant differences have been observed between 
groups; however a study by Kim et al. (2006) on highly trained male cyclists showed significant 
improvement in VT and TTE (time to exhaustion) with the same effect being found on the elderly 
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(55-92 years) (Stout et al., 2008).   If indeed carnosine concentrations increase, then beta-alanine 
supplementation must cause the same effect independent of age and sex and possibly improve 
endurance related cycling events.  However, Smith et al. (2009) investigated the effects of beta-
alanine supplementation on neuromuscular fatigue and muscle function in active men (19-26 
years of age).  Electromyographic fatigue threshold (EMGFT) and efficiency of electrical activity 
(EEA) were analyzed, and contrary to the results mentioned by Stout et al. (2007 and 2008), 
EMGFT and EEA values for both mid and post supplementation indicated no significant 
difference between the groups.  This begins a debate about why active healthy males fail to 
decrease neuromuscular fatigue following increased carnosine concentration. 
 
Addressing the issue of training in conjunction with beta-alanine supplementation on 
performance is essential for justified use of the supplement.  Subjects who performed training 5 
hours a day/6 days a week, plus 3 days a week performing weights followed by 12 weeks of 
supplementation, showed significant elevations in carnosine concentration.  This resulted in 
significant increases in VT, TTE, and isokinetic flexion (Kim et al., 2007).   
 
Based on the contradictory evidence outlined above, it is hard to definitively state that the effect 
beta-alanine supplementation has on carnosine concentration does or does not affect performance 
and/or aerobic or anaerobic parameter improvement.  Because beta-alanine research is relatively 
new, a greater understanding of the definitive role of increased carnosine concentration is needed 
both in terms of performance increase and physiological and biochemical mechanisms as 
discussed in the following section. 
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Physiological Mechanisms Responsible for Improving Athletic Performance 
There is evidence to suggest that beta-alanine supplementation improves performance both 
aerobically and anaerobically.  The underlying mechanisms, both physiologically and 
biochemically, will be reviewed in this section.  It has to be noted that there is a large group of 
studies which showed little or no effect following supplementation.  These differences may be 
attributed to differences in dosing strategies, subject training status, duration of exercise stimulus, 
unfamiliarity with tests, and supplementation duration.  Experimental protocol (4-6g/day for 6 
weeks) and thus skeletal muscle carnosine concentration was a suggestion for failure to observe 
an improvement in power through repeated sprint performance (Sweeney et al., 2010).  It has 
been clearly shown, however, that 6 weeks of supplementation of 4-6g/day is more than enough 
to significantly increase carnosine concentration above basal levels (Harris et al., 2006; Hill et al., 
2007). 
 
As fast-twitch muscle fibres produce excess H+ during repeat sprint activity, it would seem 
sensible to assume that carnosine concentration increase would delay the onset of muscular 
fatigue.  The authors suggest the reason for the absence of this phenomenon is due to the 
excessive amount of H+ produced during the activity (not actually calculated via blood or muscle 
pH) exceeding the capacity of carnosine to act as an intramuscular buffer.  This may be because a 
pH drop from 7.2 to 6.5 during high-intensity exercise (Harris et al., 2006), or repeated sprint 
activities which are purely based on the ATP-PC system, may not be affected by carnosine 
concentrations.   
 
Studies state PCr stores and fast glycolysis make up approximately half of the required energy for 
a short bout (6s) of high intensity exercise (Sweeney et al., 2010).  It is postulated that for 
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repeated sprint activities with incomplete recovery (sprint or points race), the rate of PCr 
resynthesis is governed by H+ concentration, blood, and ATP concentration within the muscle 
(Silverthorn, 2004). This lack of PCr resynthesis may be responsible for the decrease in sprint 
performance, and not pH change (Bishop., 2004).  The inadequate recovery time may have 
prevented full resynthesis of PCr as its half life is approximately 57s (Bogdanis et al. 1996).  
Further evidence (Bishop et al. 2004) suggests that metabolic reactions that absorb H+, such as 
sarcolemmal lactate/H+ or Na+/H+ exchange mechanisms, capillarization, changes in the 
intracellular strong ion difference , and muscle blood flow may be more responsible for the 
physiochemical buffering in muscle. 
 
In relation to performance improvement, Derave et al. (2007) observed no significant differences 
between groups for 400m times (approximately 50s) as stated previously.  This leads to an 
argument with the previous points of view (Sweeney et al. 2010), that maximal exercise for a 
longer duration (excess of 45s) should be significantly affected by increased carnosine 
concentration.  The discrepancy is believed to be associated with the increased intracellular 
buffering capacity being insufficient to bring about an increase in 400m time, or that decreasing 
pH is not a limiting factor to 400m performance.  Interestingly, blood and muscle pH were not 
calculated, so the pH drop is therefore purely speculative.   
 
McClaren et al. (1989) suggest the decrease in muscle pH may be responsible for fatigue-induced 
increases in muscle EMG amplitude, resulting in neuromuscular fatigue.   Furthermore, an 
increase in lactate concentration, and thus H+ accumulation, increased EMG amplitude during 
cycle ergometry (Taylor et al. 1997), lending evidence to speculation by Moritani et al. (1993) 
who suggested EMGFT activity may be closely related to lactate increase and pH decrease in 
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active muscle.  Based on this statement, beta-alanine supplementation should prevent a rise in 
EMG amplitude, delay neuromuscular fatigue, and improve cycling performance.   
 
Aside from neuromuscular fatigue, significant improvements in TTE and VT have been observed 
using beta-alanine supplementation (Stout et al., 2007) based on research by Svedahl and 
MacIntosh (2003).  In a follow-up study, (Stout et al., 2008) similar observations were made that 
were attributed to an increased carnosine concentration, and its ability to delay the onset of 
intracellular acidosis via H+ buffering (Marsh et al., 1993). 
 
Through absorbance of H+ and increased troponin sensitivity to Ca2+ in fast-twitch fibres (Dutka 
and Lamb., 2004), carnosine improves performance.  Dunnett et al. (1999) highlighted the 
buffering capabilities of carnosine in a study on 6 thoroughbred horses, where following 30 days 
of beta-alanine supplementation, skeletal muscle non-bicarbonate intracellular physiochemical 
buffering capacity was significantly increased above that of the control.  Furthermore, an increase 
(9.2-14.3%) in total muscle buffering following beta-alanine supplementation was directly related 
to an elevated carnosine concentration (Harris et al., 2006).  These results were derived from the 
Henderson-Hasselbach equation and represent underestimated values for carnosine’s 
contribution.   
 
The evidence presented about carnosine’s ability to increase performance through beta-alanine 
supplementation is equivocal.  Carnosine’s ability to buffer H+ has been shown, but whether H+ 
plays a significant role in fatigue, or carnosine’s concentration is not significantly high enough to 
observe an improvement, is yet to be determined.   
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Beta-alanine Supplementation Mimicking Lactate Tolerance Training 
Where anaerobic power is essential for success, athletes will often incorporate lactate tolerance 
training.  Improving the lactic acid clearance ability of the muscle is characterized by sustained 
efforts at or above the threshold, known as lactate threshold training.  Lactate tolerance training 
however, is characterized by maximal exercise for 20-60s in duration.  By inducing muscular 
fatigue, the skeletal muscles become accustomed to the pain and discomfort, increasing pain 
tolerance, buffering mechanisms, and capacity.  
 
For professional cyclists who utilize the ATP-PC and fast rate glycolysis systems, lactate 
tolerance training is a necessity (extend maximal performance duration). It has been shown to 
significantly increase muscle buffering capacity in anaerobic orientated sports, with subjects 
exposed to an 8 week lactate tolerance training protocol (sprint) experiencing a 16% increase in 
muscle buffering capacity in the vastus lateralis (lactate concentration 21.41 ± 1.65 mmol kg-1 to 
25.61 ± 2.38 mmol kg-1).  The increased lactate concentration signifies a higher production of 
muscle H+ ion concentration indicating increased buffering capabilities (Sharp et al., 1986).  
Further research (Bell and Wenger 1988) discovered that one legged cycle ergometer training 
(60s maximally, 4 days a week for 7 weeks) significantly increased muscle buffering capacity 
(49.9 to 57.8 µmol HCl g–1 pH–1), as well as peak and average power.   
 
With increased muscle buffering capacity developed independently through beta-alanine 
supplementation and lactate tolerance training, the combined effects of the 2 methods may cause 
a synergistic effect and substantially increase intramuscular hydrogen buffering.  It is known that 
significant increases in carnosine concentration lead to an increase in muscle buffering capacity 
(4 to 12 weeks following beta-alanine supplementation), with lactate tolerance training often 
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commencing 8 to 12 weeks before competition (based on the current New Zealand sprint track 
cycling program, 2010).  Therefore, it may be beneficial for athletes competing in sprint 
orientated events to combine the use of lactate tolerance training and beta-alanine 
supplementation. 
 
There is overwhelming evidence to suggest that oral beta-alanine supplementation significantly 
increases skeletal muscle carnosine concentration.  The majority of studies used a 4-12 week 
duration, and a dosing strategy of 2.4-6.4g/day.   The most beneficial experimental protocol for 
increasing skeletal muscle carnosine concentration is yet to be determined due to the lack of a 
“ceiling effect”.   However, there is contradictory evidence as to what effect, if any, this increase 
will have on performance, both aerobically and anaerobically.  Carnosine is an intracellular 
physiochemical buffering molecule that is capable of binding free H+ preventing their detrimental 
effect on muscle mechanics.  The percentage of total buffering capacity remains unclear until 
further research is conducted via long term studies on a variety of sports. 
 
 
Aim of the Study 
Previous research has identified the effects of beta-alanine supplementation on performance 
increase in sedentary individuals, college wrestlers, football players, and physically active 
individuals, however, there is little to no research into its effects on elite cyclists.  The aim of this 
study was to identify any possible ergogenic effects of beta-alanine supplementation for elite 
cyclists.  Due to the prevalence of beta-alanine supplementation by elite cyclists since its 
introduction a few years ago, it would be beneficial to understand the possible ergogenic effect 
on cycling capacity in trained cyclists, and whether its continued use is supported scientifically. 
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CHAPTER TWO 
Methodology 
Subjects 
Fifteen competitive cyclists (8 road, 2 road/track endurance, and 4 track sprinters) were 
approached and volunteered for this study because of their calibre in the Canterbury region.  At 
the conclusion of the study, one track sprint cyclist had withdrawn.  The withdrawl was due to 
work commitments and they were unable to attend the required dates.  All subjects had been at 
representative level (regional, national or international) for at least four years.   
 
The characteristics of the subjects who completed the study are presented in Table 4.  There was 
no statistically significant difference between the groups for weight, height, age or VO2max 
(p>0.05).  Both groups completed the required supplementation protocols of their respective 
supplement. 
 
The majority of the subjects (N=12) were recruited via personal contact with the researcher.  Two 
cyclists had received services through the University of Canterbury Sports Science Laboratory in 
the past, and 1 other was recruited through word-of-mouth.  Information (Appendices A and B) 
regarding the aims of the project, subject requirements, use of results, contact details, and a brief 
overview of the supplement involved were provided to all subjects in the recruitment process.  It 
was highlighted that any subject was able to withdraw from the experiment at any time for any 
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reason and they were encouraged to ask questions about the study.  The subjects were not 
required to pay for any part of the study and received no incentives or payment for participating.   
At the time of the experiment, all subjects were in an endurance phase and were randomly 
assigned to either the beta-alanine group (N=7) (those receiving beta-alanine crystals orally) or 
the control group (N=7) (those receiving the placebo (maltodextrin)). 
 
Table 4. Physical characteristics of the subjects who completed the study.  Data are 
representative of 14 subjects and include both male and female data. (Mean ± standard deviation) 
 
                                                       Beta-alanine            Control 
  Height (m)     1.79±0.08              1.78±0.07 
  Weight (kg)             76.3±7.2       73.9±4.0 
  Age (yrs)    20.0±1.6       21.9±2.1 
  VO2max (ml.kg-1.min-1)     60.7±4.8       56.7±5.8 
 
 
During the supplementation phase, subjects continued with their previously planned training and 
competition program.  Typical training consisted of 500 to 1000 kilometres in volume and 
encompassed a combination of flat and hill rides, ergometer training, gym work, standing start 
practice, and races varying from club rides to national championships.  Training diaries were to 
be completed for the supplementation block to account for any differences observed in the 
results. 
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Prior to the study (10 weeks), each subject was sent information regarding training, nutrition and 
the use of sporting supplements (Appendices A & B).  Each subject was advised to consume the 
same meal the night prior to and the morning of testing (on each occasion) and to refrain from 
consuming alcohol.  
 
To ensure a “clean” experiment, subjects were asked to cease the use of sporting supplements ten 
weeks prior to testing.  Ten weeks was chosen specifically because it enabled the complete 
washout (beta-alanine (9 weeks) and creatine (4 weeks) of the most common sporting 
supplements.  Caffeine however, has a half-life in smokers or heavy caffeine users of 3.2-4.1 
hours and 5.1-5.3 hours in non-users (Whitsett et al., 1984).  Each subject was subsequently 
instructed to refrain from drinking any liquid or consuming any food or pills containing caffeine 
twenty-four hours prior to testing.  One subject failed to comply with this and consumed caffeine 
(1 cup of tea) on the morning of initial testing.  To standardize the results, the subject was 
instructed to consume 1 cup of tea before each test. 
 
A summary of the health issues and physical stress precautions associated with the experiment 
(Appendix C) was provided.  Before the experiment proceeded, informed, written consent 
(Appendix D) was obtained in accordance with regulations of the University of Canterbury 
Human Ethics Committee.  
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Experimental Overview 
The study was approximately 10 weeks in length which encompassed 2 weeks of testing and a 8 
week supplementation block as seen in Figure 5.  The duration of the beta-alanine 
supplementation period was chosen specifically because it is associated with significantly 
elevated carnosine concentrations above basal level within the skeletal muscle (Harris et al., 
2006).  With all subjects having previous exposure to the testing procedures associated with the 
experiment, familiarization testing was not conducted.   
 
 
Figure 5. The experimental overview. 
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Anthropometric Analysis and Ergometer Set-up 
Subjects reported to the University of Canterbury Sports Science Laboratory for anthropometric 
analysis and testing.  Testing was conducted using the Velotron Cycle Ergometer (Figure 6) or 
Repco Cycle Ergometer (Figure 7) at approximately the same time of day to account for any 
variability in performance in time-of-day (Wyse et al., 1994).  Fluid was consumed ad lib before, 
during and after the testing (except during the VO2max testing due to mouthpiece restrictions and 
the WAnT as it was an all-out 30 second effort), and a 30cm oscillating, 3-speed fan (Model 
1231, Mistral, China) was placed in front of the subject to simulate real life cycling and the air-
cooling affect.  
 
Testing took place in an indoor, temperature controlled (19-23ºC) laboratory.  While relative 
humidity was not controlled, it was measured before every test and was constantly between 50-
60%.  Subjects were instructed to bring in their own bikes for specifications and individualized 
set-up.  The Velotron Ergometer was chosen over the Kingcycle due to its stability, power output 
control (copper flywheel controlled by magnetic force), a consistent testing set-up for all subjects, 
and familiarization of the apparatus to many of the subjects. 
 
On arrival, anthropometric analysis of the subject was conducted.  Height for descriptive 
purposes, and weight in cycling clothing using digital scales (Seca scales, model 770).  
Collection of the subject’s bike specifications followed to individualize the set-up of the Velotron 
or Repco Ergometers for the subject.  Crank length (mm), seat height (cm), seat to floor (cm), 
front of the seat behind the bottom bracket (cm), handlebar to seat (cm) and handlebar to floor 
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(cm) measurements were all taken.  In order to convert these values to the Velotron, a calculation 
had to be made to account for the stationary height of the Velotron (equation 1).  The same 
specifications were used to calculate the required lengths and heights on the Repco Ergometer.  
Both the Velotron and Repco Ergometers were connected to a PC computer. 
 
 
Equation 1.  Adjustment to calculate handlebar height on the Velotron. 
Velotron seat to floor............cm – Subject seat to floor…………cm = …………cm (A) 
Subject handlebar to floor………..cm + (A)…………cm = …………cm (required Velotron 
handlebar height 
 
 
Figure 6. Velotron Cycle Ergometer used for the VO2max and MAP tests to determine aerobic 
capacity. 
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Figure 7. Repco Cycle Ergometer used for the 30s-WAnT for determination of anaerobic 
capacity. 
 
VO2max protocol 
Prior to the supplementation period (10 days), a VO2max test was chosen as a characterization 
test.  It is commonly used as an indicator of cycling performance, although VO2max has not 
always been shown to be a good predictor of endurance capacity (Mahood et al., 2001).  VO2max 
protocol was taken from that described by Paton (2000).   
 
Using a PC computer and Velotron software, Velotron Ergometer calibration was conducted.  
The subject was instructed to initiate calibration by pedaling until the desired speed of 23km/h 
was attained.  Instructions to cease pedaling allowed the flywheel to decrease in speed to 22km/h.  
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This deceleration period allowed the software to calibrate power outputs.  If the power output 
percentage change was greater than 0.2%, the calibration process continued. 
 
A heart rate monitor strap was fitted around the chest of the subject.  Heart rate was displayed via 
a wristwatch (PE1500, Polar, Finland) that was mounted onto the aerobars of the Velotron.  A 
neoprene face mask that incorporates a hole for the mouthpiece (encloses both the mouth and the 
nose to allow for a more effective analysis) was attached to the subject’s face.  The mouth piece 
(preVent flow sensor) was then connected to the VO2max mass spectrometer as seen in Figure 8 
(Ultima CPX, Medgrpahics).  Ventilation rate and breath-by-breath analysis of oxygen and 
carbon dioxide was analysed and averaged every 20s.  The mass spectrometer was calibrated for 
oxygen, carbon dioxide and nitrogen using an automated process as described by the 
manufacturer’s instructions (Medgraphics). 
 
Figure 8. VO2max mass spectrometer (Ultima CPX, Medgraphics) used for gas analysis during 
an incremental VO2max test to determine aerobic capacity. 
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A 20 minute warm-up preceeded the test at a steady cadence and power output that was 
comfortable for the subject. Sprinting activities were strictly prohibited to prevent the build-up of 
toxic by-products.  The test began with an initial power output of 100W and subsequently 
increased by 33W every minute until the subject was unable to continue pedaling (muscle 
exhaustion), could not physically continue because of breathing constraints associated with lung 
capacity, or could not hold the required power output at a cadence above 60rpm.  The subject was 
given extensive encouragement throughout the test entirety.  All subjects lasted between 9 and 13 
minutes and absolute VO2max was taken as the highest oxygen uptake reading (averaged over 
20s) in liters, per kg, per minute. 
 
Maximum Aerobic Power Test Protocol 
Subjects completed the Maximum aerobic power (MAP) test before (7 days) and after (1 day) the 
supplementation period to determine the effect of beta-alanine on aerobic capacity.  Lactate 
analysis and the point of exhaustion determined the subject’s aerobic threshold, anaerobic 
threshold, and MAP. 
 
Pre, during, and post test blood analysis for lactate concentrations were conducted.  The lactate 
analyzer (1500 Sport, Yellow Springs Instruments Inc, Ohio, USA) as shown in Figure 9 was 
calibrated prior to each test in line with the automated procedure that requires 0 and 5mmol-1 
lactate reference points.  A known sample (5mmol-1) was injected and run through twice and if 
the reading was within the manufacturers specified error limit of ±0.1mmol-1, testing began. 
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Pre warm-up, the subject’s blood was analyzed to determine resting lactate levels.  Blood was 
removed via a heparanized capillary tube from the index fingertip of the left hand.  If it became 
increasingly difficult to remove blood from the initial prick, a further incision was made to the 
same finger or middle finger of the same hand.  A 25µL sample was drawn via pipette (Model 
1501, Yellow Springs Instruments Inc, Ohio, USA) from the capillary tube and inserted into the 
lactate analyzer according to the manufacturers’ instructions.   
 
MAP test subject set-up was in accordance with the VO2max protocol.  The test began at a power 
output of 100W and had forty watt increments every 3 minutes.  Instructions were given to the 
subject to keep the cadence above 60rpm otherwise the test would cease.  Encouragement was 
given to the subject throughout the entirety of the test.  Thirty seconds before the completion of 
each power output, a blood sample was drawn and analyzed for lactate concentration.  To 
establish MAP, the subject was given instructions to continue to exhaustion (respiratory 
exhaustion or a drop in cadence below 60rpm). 
 
MAP is determined from the penultimate power output stage completed and the time (s) at the 
stage they failed to complete.  Aerobic threshold, anaerobic threshold and MAP were calculated 
using workload (W), heart rate (bpm) and lactate concentration values.  Aerobic threshold was 
defined as a lactate concentration above “baseline” levels (the low, steady-state, lactate reading), 
and the anaerobic threshold was determined as the point at which lactate concentration suddenly 
increased above clearance levels. 
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Figure 9. The 1500 sport lactate analyzer used for determination of blood lactate concentrations. 
 
 
30s-Wingate Anaerobic Test Protocol 
The 30s-Wingate anaerobic test (WAnT) was conducted prior to (4 days) and after (4days) the 
supplementation period.  The Repco Ergometer calculates the power profile of a cyclist and is 
specifically designed to predict the anaerobic power and capacity of an individual.   
 
Calibration of the Repco Ergometer is necessary to account for day to day variation.  Calibration 
was an engineering project by the University of Canterbury using a motor/calibration rig.  The 
calibration was carried out as described in the methods by Raine (1993).   
 
The subject was given instructions to cycle maximally for 30s.  This is imperative because the 
test is used to gauge a cyclist’s anaerobic power and capacity.  Anything short of their maximum 
performance can cause misleading results.  During the test, the subject was not allowed to look at 
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their graph of power data; however they were given verbal encouragement throughout the 
entirety of the test including a 10s to go call and a 5s to go call. 
 
Once the Repco Ergometer had been specifically set-up, the subject was asked to pedal at a 
comfortable cadence and power output for 20 minutes.  This allowed for adequate blood flow 
through the skeletal muscles of the legs (Bishop, 2003) which is an important aspect of any 
cyclist’s ability to perform at any level (Burnley et al., 2005).  Following the completion of the 
warm-up, the subject was asked to stop pedaling (to allow the hand held brake to be applied) and 
then perform a 4 second maximum effort.  This stimulates the neurological pathway associated 
with muscle activation and relaxation.  It is crucial because of the high cadence activity 
associated with maximum effort on the Repco Ergometer and allows the subject to activate their 
central nervous system (CNS) and stimulate maximum firing patterns.  Following the 4 second 
effort, the subject pedaled lightly for 5 minutes.  This gave the muscles adequate time to recover 
and expel any toxic by-products.  The theory behind CNS activation in repeated cycling 
ergometer training has been difficult to prove; however results have shown that the second 
maximum effort produces greater power (Glaister et al., 2003).   
 
Gear selection is an important aspect.  The subject was instructed to choose which gear they felt 
comfortable with.  Because most of the subjects had completed such a test before, they chose on 
past performances.  For the minority (N=5) of the group who had not completed a WAnT test, 
advice from the researcher was given.  The ergometer has 7 gears to choose from.  Each subject 
used gears 2-5, 5 being the hardest and associated with a slower cadence.  It was explained to the 
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subject that the gear chosen for the first 30s-WAnT would have to be the same gear used for the 
second.  A hand-held mechanical brake held the subject and flywheel (Figure 8) in place.  With a 
5s countdown the subject proceeded to cycle maximally for 30s.  At the completion, the subject 
was instructed to pedal lightly for 5-10 minutes to allow for the release of any anaerobic by-
products.  Data collected from the test provided the subject’s power over the 30s test as indicated 
by Figure 10.  Peak power, finishing power, watts per kilogram, and average power were all 
provided.  Fatigue Index was calculated using the following equation. 
 
 
Equation 2. Fatigue Index calculation using data from the WAnT. 
Peak power – Finishing power / Peak power = Fatigue Index (% change) 
 
 
Figure 10. Repco Ergometer data analysis readout example following a 30s-WAnT. 
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Experimental Protocol 
At the conclusion of the first set of testing, the 8 week supplementation protocol began.  Beta-
alanine is a commercially available substance and is commonly used throughout the sporting 
community for performance increase.  Beta-alanine was ordered in ten one kilogram bags and 
was subsequently split into 7 separate containers labeled carefully with the subjects’ names and 
the required dosage.  Five ml vials were used to carefully provide the supplement in the required 
amount (3.2g per serving) and transfer to a 200 ml glass of water.  Subjects were instructed to stir 
in the powder until it had dissolved and then consume.  Consumption was twice per day for the 
duration of the experiment.  The same protocol was associated with the control group 
(maltodextrin).  Maltodextrin is commonly used as a control (Derave et al., 2007) because of its 
close resemblance (white crystalline powder) to beta-alanine.   
 
Prior to the study (10 weeks), subjects were provided with written and verbal information from 
the researcher regarding potential risks associated with the consumption of the substance.  Such 
risks commonly associated with beta-alanine supplementation is paresthesia or the “tingling 
sensation” and can last anywhere from 10 to 45 minutes.  
 
Statistical Analysis 
To gain a better understanding of the results, mean analyses and both within and between groups 
variances were conducted.  The results are presented as mean ± SD.  This method was employed 
to take into account the types of training each of the subjects had done previously to see if that 
had had any effect on the results that the ANOVA may not have picked up. 
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The mixed design ANOVA was used to detect any differences within group and between groups 
for treatment and the statistical significance was set to 5% (p<0.05).  VO2max, weight, age, 
height, maximum aerobic power (MAP), anaerobic threshold, aerobic threshold, watts per 
kilogram (W/KG) of MAP, fatigue index, average power, average W/KG, peak power, finishing 
power, training volume, training intensity and final lactate concentrations were all analyzed using 
this method.  Data were analyzed using the Statistical Package for Social Sciences (SPSS) and 
Microsoft excel 2007.  
 
 
Funding 
Beta-alanine production companies funded no part of this study nor took part in any planning or 
implementing the design of the study.  This policy protects the study from alleged bias toward 
results that could be used for commercial gain by the manufacturer. 
 
The study was supported with the funding from The Biological Sciences Department at The 
University of Canterbury and with help from the University of Canterbury Recreation Centre, in 
particular the Sports Science Laboratory. 
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CHAPTER THREE 
Results 
In this chapter the descriptive data and inferential analysis findings for the study are presented.  
The descriptive data are presented as mean ± SD.  Subjects completed a MAP test and 30s-
WAnT on separate days pre and post supplementation.  The MAP test and 30s-WAnT were used 
to analyze whether 8 weeks of 6.4g/day beta-alanine influenced aerobic and/or anaerobic capacity 
parameters respectively in trained cyclists.   
 
 
Training Volume and Intensity 
Training intensity and training volume for the control and beta-alanine groups are shown in Table 
5.  During the 8 week supplementation block, there was no significant difference between the 
control and beta-alanine groups for training volume (F(1,9) = 0.599, p = 0.459) and training 
intensity (F(1,9) = 0.218, p = 0.652).  Training intensity was characterized as one of three levels.  
Flat terrain training session from 1 to 4 hours in duration were classified as a 1, an ergometer 
session or long (3 hours +) hill ride was classified as a 2, and sprint training exercises or gym 
work was classified as a 3.  Following the supplementation period, intensity values were added 
up and averaged over the total number of training sessions completed. 
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Table 5. Average training volume and intensity for the control and beta-alanine groups during 
the 8 weeks of supplementation. (mean ± SD)   
Parameters Control Beta-alanine                     
Training volume 
(minutes/week) 
746±134.2 760±160.1 
 
Training intensity 
 
1.71±0.4 
 
1.95±0.4 
 
 
MAP Test 
The control and beta-alanine groups completed a MAP test pre and post supplementation.  As can 
be seen in Table 6, there was minimal change for both groups over time for maximum aerobic 
power (MAP), aerobic threshold (AeT), and anaerobic threshold (AnT).  The trend in the data 
also shows very little change in the final lactate concentration and watts per kilogram (W/KG) of 
MAP for both groups.  AeT for the control group decreased following the experimental protocol 
(Table 6), whereas the beta-alanine group saw a rise of 8.6W following the supplementation 
period.  Of interest is the change in final lactate concentration of the beta-alanine group.  The 
1.63mmol-1 decrease in average lactate concentration was caused by subject 9 whose 
concentration of 5.83mmol-1 was low in comparison to the 13.57mmol-1 attained in the first MAP 
test.   The lack of change in the parameters (mean) resulted in there being a non-significant 
difference between groups for MAP (F(1,12) = 1.398, p = 0.261), AeT (F(1,12) = 0.759, p = 0.401), 
AnT (F(1,12) = 1.070, p = 0.321), final lactate concentration (F(1,12) = 1.983, p = 0.184), and W/KG 
of MAP F(1,12) = 1.054, p = 0.325).  Based on these results, 8 weeks of 6.4g/day beta-alanine does 
not significantly change the MAP, AeT, AnT, and W/KG of MAP in trained cyclists. 
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Table 6. Average aerobic capacity parameters following the MAP test pre and post 
supplementation for the control and beta-alanine groups. (mean ± SD) 
 
Parameters 
            Control 
Pre 
                     
Post 
     Beta-alanine 
 
Pre 
        
 
Post                 
MAP (W) 358.6±38.0 358.0±34.6 395.7±72.2 384.3±54.2 
AeT (W) 221.4±27.9 212.9±30.4 
 
235.7±67.8 244.3±61.3 
AnT (W) 295.6±37.8 
 
293.6±31.7 
 
322.1±72.3 
 
321.4±57.3 
W/KG of MAP 4.8±0.4 
 
4.9±0.3 
 
5.2±0.8 
 
5.2±0.7 
Final [La-] (mmol-1) 10.1±1.5 
 
10.0±2.4 12.3±1.7 10.6±3.2 
 
 
30s-WAnT 
Subjects completed a 30s-WAnT pre and post supplementation 3 days after the completion of the 
MAP test.  The trend in the data was as shown in Table 7 and indicates minimal change occurred 
for both groups over time for peak power, minimum power, fatigue index (FI), average 30s 
maximum power, and average watts per kilogram (avge W/KG) of 30s maximum power.  The 
minimum power decreased in the control group (45.3W) and increased in the beta-alanine group 
(26.3W), however both were non-significant.  There was a non-significant difference between the 
control and beta-alanine groups for peak power (F(1,12) = 0.533, p = 0.479), minimum power 
(F(1,12) = 0.907, p = 0.360), average 30s maximum power (F(1,12) = 1.122, p = 0.310), avge W/KG 
of 30s maximum power (F(1,12) = 0.827, p = 0.381), and FI (F(1,12) = 0.004, p = 0.953).  Based on 
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these results, 8 weeks of 6.4g/day beta-alanine does not significantly change any of the above 
anaerobic capacity parameters. 
 
Table 7. Average anaerobic capacity parameters following the 30s-WAnT pre and post 
supplementation for the control and beta-alanine groups. (mean ± SD) 
 
Parameters 
          Control 
Pre 
                     
Post 
     Beta-alanine 
 
Pre              
        
 
Post                 
FI (%) 59.9±6.4 58.7±5.7 61.0±6.9 57.2±7.8 
Avge 30s max 
power (W) 
 
835.3±137.6 789.6±149.8 
 
899.1±142.2 884.7±134.5 
Avge W/KG of 30s 
max power (W) 
 
11.2±1.7 
 
10.8±1.8 
 
11.9±1.4 
 
11.7±1.5 
Peak power (W) 1339.0±251.2 
 
1280.4±268.8 
 
1434.3±321.5 
 
1412.3±321.4 
Minimum power 
(W) 
555.3±86.8 
 
510.0±78.5 556.3±84.2 582.6±72.3 
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CHAPTER FOUR 
Discussion 
 
Effect of Beta-alanine on Aerobic and Anaerobic Capacity 
The aim of the study was to examine the effect of an 8 week 6.4g/day beta-alanine 
supplementation protocol on aerobic and anaerobic capacity in trained cyclists.  My study did not 
detect any significant difference between the beta-alanine and placebo groups following 
supplementation over time for any of the parameters measured.  The lack of change in aerobic 
parameters is supported by previous evidence (Stout et al., 2007), while anaerobic capacity 
parameter evidence provided by Sweeney et al. (2010) and Hoffman et al. (2006) is similar to the 
current study also.  Discrepancies in relation to Derave et al. (2007) and Kern et al. (2010) may 
be related to experimental protocol length, dosage, and/or the training status of the subjects.   
 
With approximately two decades of research into the potential ergogenic effect of increased 
carnosine concentration through beta-alanine supplementation, evidence presented in this field is 
equivocal.  Some suggest there is an ergogenic effect (Hoffman et al., 2006), while other studies 
offer little proof of such an event (Derave et al., 2007).  It has to be recognized that there is 
substantial evidence (Harris et al., 2006; Hill et al., 2007) of increased skeletal muscle carnosine 
concentration following a beta-alanine supplementation protocol.  A 37-47% increase in skeletal 
muscle carnosine concentration in the soleus and gastrocnemius has been identified (Derave et 
al., 2007), with an increase as high as 80% following 10 weeks of supplementation (Hill et al., 
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2006).  Both studies were associated with an increase in performance suggesting there may be a 
potential ergogenic effect, however, my study did not detect such a change assuming an increase 
in skeletal muscle carnosine concentration.    
 
Due to the inability to conduct a cross over design (scheduling issues associated with elite 
athletes), I cannot conclude that beta-alanine supplementation does not improve capacity.  
Identifying capacity change was not aided by the statistical power of this experiment (7 subjects 
per group); therefore a future study examining the same protocol on a significantly greater 
number of subjects would be beneficial. 
 
 
Experimental Protocol 
Previous research (Harris et al., 2006) identified significant increases in skeletal muscle carnosine 
concentrations (42.1-65.8%) following 4 weeks beta-alanine supplementation (3.2-6.4g/day).  
Due to the significant cost of proton MRS ($1000/hr) and the objection of subjects to invasive 
muscle biopsies (prevent training), identifying the possible rise in skeletal muscle carnosine 
concentration was not possible.  Therefore, based on assumption and previous evidence (Harris et 
al., 2006, Hill et al., 2007), an increase in skeletal muscle carnosine concentration in the beta-
alanine group would have been expected.   
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The current study utilized a 3.2g twice a day strategy, unlike previous studies (Kendrick et al., 
2009) which subjected subjects to a 400-800mg dose.  The 400-800mg dose is thought to prevent 
the effect of paraesthesia, and any associated problems with the current strategy are specific to 
timetable constraints and transport issues.  All subjects involved were current students or full-
time employees, which would have caused issues with administering the correct dose at the 
correct time.  Therefore, a 3.2g dosage was employed every morning and evening to ensure an 
uncomplicated effective protocol.  Some of the subjects (N=4) commented on paraesthesia, but as 
a result of previous consumption, all were well aware of the ensuing feeling, and were able to 
cope. 
 
The 3.2g serve may have caused alterations to the rate and total increase in skeletal muscle 
carnosine concentration.  There is a rate limit to beta-alanine absorption (number of β-amino 
transporters) due to the identification of a beta-alanine saturation level within the gastrointestinal 
tract (Harris et al., 2006).  Therefore, the absorption rate and percentage of the 3.2g dose may 
alter final carnosine concentration, and thus capacity.   
 
With evidence showing 10mg.kg-1.day stimulates 10-70% Vmax of transporters over time (Harris 
et al., 2006), it is possible that the increased dosage may in fact enhance carnosine synthesis.  
However, following initiation of carnosine synthesis (carnosine synthase), the degradation 
(carnosinase) may alter total carnosine concentration.  Due to the stability of carnosine, the 
degradation timeline is increasingly slower than other molecules studied thus far (Baguet et al., 
2009).  Approximately 10 weeks will be required for carnosine levels to return to baseline in 
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individuals who increase their concentration by 55%, and 20 weeks for individuals who increase 
their levels by as much as 80%.   
 
Subject Responsibility 
Subject responsibility is a major discussion point for study reliability.  Based on data published 
concerning beta-alanine (Baguet et al., 2009), and creatine washout (Greenhaff, 1995), subjects 
were asked to refrain from beta-alanine and creatine supplementation 10 weeks prior to the study.  
With creatine significantly enhancing sprint performance (Volek et al., 1997), failure to comply 
could significantly alter results.  Subjects may also have unknowingly ingested a significant 
portion of beta-alanine naturally through the consumption of chicken, beef, or pork.  Increases in 
carnosine concentration following the ingestion of chicken broth were identified (Harris et al., 
2006), equivalent to 10mg.kg-1.bwt per day.  However, it is unlikely that this had an effect, as the 
aerobic and anaerobic capacity parameters for both the control and beta-alanine group did not 
change (although consumption of beta-alanine through foods was not controlled). 
 
Kern et al. (2010) and Stout et al. (2008) observed significant improvements in performance 
following beta-alanine supplementation, while others (Smith et al., 2009) failed to see such an 
effect.  There was a lack of change in aerobic and anaerobic capacity following beta-alanine 
supplementation in the current study.  It has been established that elite athletes have a carnosine 
concentration baseline that is significantly elevated above sedentary individuals (Parkhouse et al., 
1985), suggesting 8 weeks of 6.4g/day was insufficient to substantially increase carnosine 
concentration above this.  Similar findings were published (Derave et al., 2007), suggesting 400m 
59 
 
running times were not significantly increased in sprint athletes due to the subjects’ training 
status which correlates well to the kilo. 
 
An investigation into the effects of repeated creatine supplementation on total PCr stores 
concluded that following initial supplementation, total PCr stores rose by 45%, followed by a 
22% decrease after a 30 day washout period, and rose again significantly by 25% following 
another 5 day cycle (Rawson et al., 2004).  This indicates 1 of 2 possibilities; there is either a PCr 
store maximum limit, or the second dosing cycle failed to raise PCr stores to the achieved level of 
the first cycle.  In relation to the current study (in which the majority of the subjects had used 
beta-alanine previously), a mechanism preventing carnosine concentrations achieving the level 
attained by initial supplementation may be involved.  I can only speculate as to what this 
mechanism may be, but I suspect that it may be a similar response to that observed in multiple 
creatine exposure studies.  Creatine transporters responsible for extracellular creatine absorption 
become down-regulated (Guerrero-Ontiveros and Wallimann, 1998) with continual creatine 
supplementation.  It is when the upper limit within skeletal muscle is attained (150-160mmol.kg-1 
of dry muscle) that creatine transporter synthesis declines and/or stops completely.  In relation to 
continual beta-alanine supplementation (which may have been the case for the subjects involved 
in this study), a decline in β-amino transporter synthesis (responsible for beta-alanine absorption) 
may occur, although to date, a “ceiling effect” has yet to be determined. 
 
A training effect, placebo effect, and/or carbohydrate ingestion may have played a role in the 
current study.  The timing of the study was specifically chosen to try and control training volume 
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and intensity.  A training effect may not have been a causative factor influencing results as 
indicated by Table 4 (training volume and intensity).  With relation to tiredness, accumulation of 
metabolic by-products, and/or dehydration, all of which have been known to disrupt exercise 
performance (Cheung et al., 2003; Maughan, 2003; Shirreffs, 2005), training in the week prior 
may have caused varying results because of test intensity. 
 
The current research was a blind study.  However, prevention of subjects determining treatment 
was impossible leading to the lack of a placebo effect due to paraesthesia accompanying beta-
alanine supplementation.  Controlling this situation meant tests independent of effort and 
motivation were conducted (Step test).  Subjects could not unduly influence any of the blood 
parameters utilized within this test.  With relation to the use of beta-alanine as a sports 
supplement in elite cycling, it is not to say it does not significantly improve capacity indirectly.  
By telling the cyclist population that consumption of beta-alanine will improve performance, they 
subsequently train harder and improve performance, a true placebo effect. 
 
Beta-alanine supplementation studies have failed to identify any possible effect hydration and 
carbohydrate ingestion may play on performance.  Hypohydration and dehydration can degrade 
exercise capacity (Maughan, 2003) and may alter results.  Carbohydrate ingestion was only 
controlled for the evening prior to and morning of the tests with subjects receiving instructions 
regarding food consumption (eat exactly the same food prior to both sets of testing).  It has been 
shown (Sparks et al., 1998) that pre-exercise carbohydrate intake does not alter performance, 
however, evidence of repeated solid carbohydrate feedings maintaining blood glucose levels, 
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reducing muscle glycogen during prolonged exercise, and enhancing sprint performance at the 
end of such activity have been provided (Hargreaves et al., 1984).  If not intentionally kept 
constant, carbohydrate and hydration levels may have influenced aerobic capacity parameters due 
to the length of the current study (including warm-up) at 33-45 minutes in duration. 
 
Fatigue and Buffering Mechanisms 
A lack of change following 8 weeks beta-alanine supplementation may be two-fold based on 
previous observations (Derave et al., 2007).  Either assumed elevations in carnosine 
concentration were not sufficiently high enough to increase the physicochemical buffering ability 
of the skeletal muscles, or an increase in H+ plays one of many roles in fatigue. 
 
Due to its acidic properties and the subsequent acidosis that arises, excess H+ structurally change 
enzymes linked to ATP production and alter transport mechanisms (Hultman and Sahlin, 1980) 
and substrate availability.  When pH drops as low as 6.5 (Davey, 1960), the fundamental 
mechanics of muscle contraction are hampered with the accumulation of excess H+.  This occurs 
through inhibition of the actomyosin ATPase (which is solely responsible for the breakdown of 
ATP), prevention of cross bridge formation (Cooke et al., 1988) and relaxation, and decreased 
Ca2+ release/absorption from the SR (Lamb et al., 1992).  Excess concentration can also alter 
calcium-troponin binding, and induce neuromuscular fatigue via EMG amplitude increase 
(Taylor et al., 1997).  In association with metabolite accumulation, performance/capacity can 
decrease.   
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It would seem safe to assume that acidosis (pH decrease) significantly influences fatigue during 
glycolytic fibre activation (sprint cycling (Ross et al., 2001)).  With no change in aerobic and 
anaerobic capacity in the experimental group, it has to be assumed that either the assumed 
increase in carnosine concentration was insufficient to buffer this H+ ion concentration increase, 
baseline carnosine concentrations were already significantly elevated with supplementation 
having little to no effect, or other factors are associated with fatigue.  With carnosine and 
anserine making up to 40% of total muscle buffering (Davey, 1960), it could be assumed that the 
carnosine concentration was not sufficiently high enough to buffer the increased H+ ion 
concentration.  With respect to recent evidence, however, (7% role in total muscle buffering, 
(Mannion et al., 1992)), it would suggest irrespective of carnosine’s concentration increase, the 
ability to improve capacity via physicochemical buffering is not solely reliant on the H+ buffering 
mechanisms of carnosine.   
 
Other possible physicochemical buffering options are employed in the muscle, and suggested to 
play a significant role in H+ ion buffering.  Metabolic reactions that remove H+ such as 
sarcolemmal lactate/H+ and Na+/H+ exchange mechanisms, as well as capillarization, muscle 
blood flow, and changes in the intracellular strong ion difference, may be more responsible for 
the physicochemical buffering in muscle (Bishop et al., 2004).  Based on this evidence, 
increasing carnosine concentration may only play one of many roles associated with fatigue. 
 
In a review by Allen et al. (2008), it was suggested that human muscle fatigue often occurs 
without a large increase in H+.  With a minor drop in muscle pH (6.9), rat gastrocnemius muscle 
tetanic force has been shown to significantly decrease by 60% (Baker et al., 1994) clearly 
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indicating the association of muscular fatigue with other factors.  Furthermore, when fatigued 
muscle undergoes a rest period, force production regenerates substantially faster than pH levels.  
This indicates that low pH per se is not solely responsible for force reduction (Baker et al., 1993; 
Cady et al., 1989).   
 
Isolated mammalian muscle research at physiological temperatures and significantly low pH 
levels (6.3), has highlighted the true effect of increased H+ ion concentration on anaerobic and/or 
aerobic capacity.  At 37°C and pH 6.3, cat muscle force production decreases by 5-10% (Adams 
et al., 1991), while at 32°C and pH 6.67, mice muscle maximal tetanic force decreases by a mere 
10% with no significant slowing of maximum velocity shortening (Westerblad et al., 1997).  
Based on the evidence, a lack of change in aerobic and anaerobic capacity during the current 
study may be associated with other factors other than an increase in H+ ion concentration. 
 
As H+ ion concentrations increase, Ca2+ affinity for the SR Ca2+ATPase pump decreases 
(Donaldson et al., 1978; Allen et al., 2008).  During high intensity exercise, this concentration 
increase would be expected to reduce skeletal muscle force production and rate of contraction.  
Therefore, with an assumed increase in carnosine concentration, anaerobic capacity should 
improve.  Results however, indicate anaerobic capacity did not change following beta-alanine 
supplementation.  This lack of change may be because evidence has suggested H+ increase 
skeletal muscle force production (removal may decrease force production).  Reasoning is 
twofold; firstly, H+ compete for troponin C’s binding site reducing Ca2+ affinity (twofold) (Baker 
et al., 1995), and secondly, Ca2+ affinity for the SR Ca2+ATPase pump is reduced.  
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Demonstration of such events was shown to occur when pH reduction (7 to 6.3) identified a 
fivefold decrease in affinity (Ca2+ for SR Ca2+ATPase pump) (Wolokser et al., 1997).  Due to this 
vast affinity difference, at acid pH, Ca2+ concentration is consequently higher, leading to an 
increased skeletal muscle force response (Baker et al., 1995).  Therefore, a pH decrease during 
intense exercise may be responsible for maintaining force production.  Based on the information 
provided, lack of capacity change in the experimental group may be associated with absorption of 
excess H+ (assumed carnosine concentration increase) decreasing skeletal muscle force 
production. 
 
Increasing capacity/performance through beta-alanine supplementation and subsequent carnosine 
concentration is well established (Derave et al., 2007; Kern, 2010; Stout et al., 2007 and 2008).  
However, the dominant energy system and duration of maximal effort determines the total 
ergogenic effect of the supplement. 
 
A 16% increase in total work performed during 150s of exhaustive exercise at 110% max power 
output was demonstrated (Hill et al., 2007).  Similarly, significant fatigue improvement following 
5 bouts of maximum voluntary contraction (45s each) was observed also.  The current study 
utilized a 30s-WAnT, the standard gauge of anaerobic capacity.  In this case, test duration may 
not have been long enough to utilize the H+ buffering abilities of carnosine, indicating other 
factors influencing capacity.  Future carnosine research should incorporate maximal effort 
duration of 45s or more to allow substantial incorporation of the anaerobic system (fast rate 
glycolysis) and subsequent metabolite accumulation.   
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The accumulation of toxic metabolites may be a significant cause for muscular fatigue during 
maximal exercise (less than 45s in duration).  Alterations to muscle machinery may prevent the 
necessary skeletal muscle force production being accomplished.  Accumulation of La-, H+, ADP, 
Pi, IMP, NH3, Mg2+, and inorganic phosphate (PO4-), a decrease in PCr synthesis, and an increase 
in extracellular K+ all result in muscular fatigue.  Based on this accumulation, it would seem safe 
to suggest a decrease in pH is only one of many limiting factors involved in aerobic and 
anaerobic capacity of maximal contraction (45s duration or less).  
 
 
An example of such is ADP, the result of the high energy splitting of ATP (Westerblad et al., 
2002) during cross-bridge formation (McLester Jr, 1997).  During fatigue, this accumulation can 
cause a slowing of the rate constants (decreased velocity of muscle shortening), and thus power 
output.  In combination with ADP, PO4- accumulation reduces skeletal muscle force production 
through the prevention of Ca2+ release (SR Ca2+-ATPase pump) (Allen and Westerblad, 2001), 
and through its profound effect on skeletal muscle force reduction (Phillips et al., 1993).  During 
a cycling sprint, PCr stores become depleted resulting in an increase in phosphate ions (Hirvonen 
et al., 1987), decreasing force production, and subsequently affecting anaerobic capacity.  A 
combination of ADP and PO4- has been shown to decrease force production, and may explain 
why aerobic and anaerobic capacity parameters did not change following beta-alanine 
supplementation. 
 
Due to the WAnT duration (30s), a decrease in pH may not have been responsible for a lack of 
change in anaerobic capacity as shown during short repeated exercise bouts (Sweeney et al., 
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2010).  PCr stores and fast glycolysis each make up approximately half of the required energy 
during short exercise (6s) (Sweeney et al., 2010).  It is therefore postulated for repeated sprint 
activities with incomplete recovery (scratch and points races), that PCr resynthesis rate governs 
muscular fatigue.  In conjunction, a lack of PCr resynthesis may be responsible for a decrease in 
sprint performance, not H+ ion accumulation (Bishop, 2004).  The toxic effects of metabolite 
accumulation (H+) may not solely be responsible for fatigue in terms of the current study (a 30s 
non-repeat test) based upon other physicochemical buffering mechanisms mentioned previously. 
 
 
The current study found there to be no significant difference between groups for any of the 
anaerobic capacity parameters (Table 6).  It is possible without controlling for these other 
previously discussed mechanisms; one or more may have been responsible for a lack of change 
between the 2 groups. This lends evidence to the belief that H+ accumulation may only play one 
of many roles in muscular fatigue. 
 
 
Genetic Profile on Carnosine Synthesis 
Pharmacogenetics is the study of how genetic variability impacts on desired and undesired drugs, 
and a legitimate reason why there was a lack of change in aerobic and anaerobic capacity 
following beta-alanine supplementation.  In relation to beta-alanine absorption and carnosine 
synthesis rate, there is a real possibility that a lack of change is associated with this phenomenon 
using evidence presented in a creatine study (Syrotuik and Bell, 2004).  Irrespective of the 
supplementation protocol, skeletal muscle creatine concentrations can vary between individuals 
based upon their biological profile (initial creatine levels, number of type II muscle fibres and 
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greatest preload muscle fibre cross sectional area) and explain why there is equivocal evidence in 
creatine supplementation studies. 
 
A favourable preexisting biological profile determines the final extent to which individuals 
respond to supplements (Syrotuik and Bell, 2004).  Subjects are less likely to gain the full 
benefits of creatine supplementation if they have a higher pre-load level of creatine, less type II 
fibres, small pre-load muscle cross sectional area, and a lower fat-free mass.  In regard to this 
theory, extracellular concentrations of glucose have been shown to influence inter subject 
creatine stores and capacity variability (Harris et al., 1992; Terjung et al., 2000; Williams et al., 
1999). 
 
Even with a high pre-existing skeletal muscle carnosine concentration, subjects supplementing 
with beta-alanine can still significantly elevate concentrations (Derave et al., 2007).  Although a 
lack of research on beta-alanine response is available, a number of biological variables underlie 
the carnosine concentration increase among individuals.  Such variables may include β-amino 
transporter abundance and activity within the gastrointestinal tract, Na+ channel abundance and 
activity (beta-alanine transportation), carnosine synthase and carnosinase activity, and histidine 
abundance within the body.  Individuals who can maximize all of these activities will increase 
their carnosine concentration by the greatest amount. 
 
When a beta-alanine group increased skeletal muscle carnosine concentrations significantly (Hill 
et al., 2007), there was a percentage increase variability within the group.  Following 4 weeks 
beta-alanine supplementation, concentrations varied from 7-13.4mmol kg-1.  After 10 weeks, 
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concentrations were 11.9-18.5mmol kg-1 above pre-supplementation level.  It is clear some 
individuals utilize beta-alanine more efficiently than others.   
 
The current study identified subjects 9, 14, and 15 showing substantial fatigue index decreases 
(64.4 to 57.3%, 64.7 to 58.1%, and 65.6 to 49.7% respectively), further highlighting the 
importance of a biological profile.  Furthermore, carnosine washout rate in “responders” has been 
identified at 3.5%/wk and 2.5%/wk in “non-responders” (Baguet et al., 2009); suggesting 
carnosinase enzyme activity is different between individuals.  This evidence may indicate why a 
lack of change in aerobic and anaerobic capacity in the beta-alanine group was observed, and the 
need for a biological profile among subjects for future studies. 
 
 
Study Limitations 
There were several study limitations associated with the current study.  A lack of statistical power 
(14 subjects) may have prevented beta-alanine’s true effect on aerobic and anaerobic capacity.  
Study nature (elite athletes) and scheduling issues (training/racing commitments) restricted 
subject availability in comparison to similar research (Hill et al., 2007); whose 25 subjects 
significantly increased statistical power.  
 
 
Training between individual subjects was not controlled for two reasons.  Firstly, each subject did 
not want to conform to a modified training schedule which may have disrupted their capacity 
and/or volume, or their intensity.  Secondly, the true effect of beta-alanine supplementation on 
elite cyclists would not have occurred (problematic issue studying elite athletes of any variety, is 
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the response the training effect has on results).  Conducting the study in this nature gave the true 
effect of beta-alanine supplementation on elite athletes (response to the substance may vary 
among types of athletes and the stage of training).  However, training in the week leading up to 
testing (both occasions) may have caused varying results due to tiredness, accumulation of 
metabolic by-products within the muscles, muscle soreness, or even dehydration, which have 
been known to disrupt exercise performance (Cheung et al., 2003; Maughan, 2003; Shirreffs, 
2005).   
 
Conducting a quantification test via proton MRS or muscle biopsy (skeletal muscle carnosine 
concentration analysis) would have been advantageous.  Refusal to undergo an invasive 
procedure and cost related issues meant performing these tests was impossible.  Analysis would 
have indicated skeletal muscle carnosine concentrations following the experimental protocol.  
Based on previous research (Harris et al., 2006), it can only be assumed the study protocol 
significantly increased skeletal muscle carnosine concentrations which did not change aerobic or 
anaerobic capacity parameters in the experimental group.   
 
If subjects underwent a biological profile, this would have further enhanced the validity and 
overall power of the research. Analysis would have incorporated muscle fibre analysis (type and 
distribution), baseline carnosine concentration analysis, and carnosinase and carnosine synthase 
enzymatic activity.  Identification of “responders” and “non-responders” to beta-alanine 
supplementation and carnosine synthesis could have explained why this study, and others like it 
70 
 
(Sweeney et al., 2010), did not observe a change capacity and/or performance in comparison to 
others (Derave et al., 2007).   
 
Neglecting blood and/or muscle pH measurement has been a common theme of beta-alanine 
research thus far.  Cases where lactate ion concentrations have increased (exercise) following 
beta-alanine supplementation (Zoeller et al., 2007), leads to the assumption that subjects with an 
increased skeletal muscle carnosine concentration produce more lactate ions during exercise.  
This would be made possible through the increased physicochemical buffering ability of 
carnosine (absorbing excess H+ maintaining an alkaline pH).  In this study, blood and muscle pH 
measurements were not conducted, and the subsequent acidosis effect can only be assumed once 
again.  It would therefore be advantageous to analyze blood and muscle pH, pre and post 30s-
WAnTs.  This would determine whether an increase in lactate ion concentration corresponded to 
a decrease in pH, or whether the increased skeletal muscle carnosine concentration utilized its H+ 
buffering ability keeping pH neutral for increased exercise capacity.  It has to be noted however, 
that final lactate concentrations did not significantly differ between groups. 
 
Subject motivation and reliability is a study limitation.  Elite subject use brought into account the 
law of diminishing effects.  The law of diminishing effects would suggest significant 
improvement observations are hard to come by.  It states that the closer an athlete gets to their 
biological limit, the less effect can be gained from the same training compared to someone far 
from their biological limit. It has to be noted that elite athletes have been shown to be more 
reliable than non-elite athletes in tests used to simulate performance (Hopkins et al., 2001).  In 
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comparison with other studies (Stout et al., 2008), use of elite athletes (VO2max = 60.7 ± 
6.8mmol.kg-1.min-1) meant there was a chance the subsequent increase in skeletal muscle 
carnosine concentration following beta-alanine supplementation may not have been sufficient to 
significantly increase aerobic and/or anaerobic capacity.  This may be because elite athletes 
already have effective buffering systems in place simply because their training regimes demand 
this, and the addition of more carnosine to their skeletal muscle might not elicit much, if any 
change. 
 
Future Research 
Beta-alanine supplementation future research needs to address a few aspects to further the 
knowledge of this supposed performance enhancing supplement.  Consideration of a biological 
profile will give us greater insight into not only the synthesis rate and percentage increase, but 
determine why or why there was not a change in capacity or performance.  An example may 
include subjects significantly improving their performance while 2 others failed to show such 
change.  Further analysis of their biological profile might give insight into why this was. 
 
Experimental protocol is an important aspect into performance/capacity improvement.  Future 
research needs to identify the rate of carnosine synthesis as there appears to be no “ceiling effect” 
for this molecule within skeletal muscle.  A study at least 24 weeks in duration utilizing both elite 
and sedentary subjects should suffice.  In combination, proton MRS or muscle biopsy analyses 
needs to be conducted every 2 weeks to gauge the synthesis rate.  In conjunction with duration, 
dosing protocol needs to be carefully considered.  The maximum dosage utilized thus far is 
6.4g/day.  Because paraesthesia occurs with 10mg.kg-1.bwt, increasing the dosage could be 
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considered difficult.  If, however, multiple 800mg doses several times a day were directed, 
10g/day could be achieved.  In conjunction with a 10g/day, 24 week study, beta-alanine’s 
complete effect on skeletal muscle carnosine synthesis can be identified. 
 
Elite and world class athletes dominate the use of beta-alanine supplementation.  It would seem 
beneficial for future research to identify beta-alanine supplementation effects on a variety of 
world class athletes, taking into account the law of diminishing effects (subjects close to their 
biological limit).  Furthermore, the effects of supplementation should be considered on actual 
sporting events.  For example, the use of a kilometer time trial or 4 kilometer pursuit should be 
considered for anaerobic capacity over a 30s-WAnT.  Furthermore, studies should include a 
variety of tests on both men and women as the physiological effects of beta-alanine 
supplementation may differ between sexes.   
 
 
Conclusion 
Various experimental protocols have changed duration and dosing strategy to examine the effects 
of beta-alanine supplementation on aerobic capacity, anaerobic capacity, neuromuscular fatigue, 
carnosine synthesis, and performance improvement.  Results, however, have been equivocal thus 
far.  The data from this study identified that aerobic and anaerobic capacity did not change 
following beta-alanine supplementation in highly competitive cyclists who underwent a similar 
training regime.  The lack of a significant improvement suggests that the assumed increase in 
carnosine concentration was insufficient to utilize its physicochemical buffering ability, subject’s 
basal level carnosine concentrations were significantly elevated where beta-alanine 
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supplementation would not alter its concentration, and/or pH only plays one of many roles 
associated with muscular fatigue. 
 
Based on the data provided, it would seem like a waste of time for elite cyclists to spend money 
on beta-alanine to elicit a performance/capacity improvement.  The law of diminishing effects 
states that being in close proximity to their biological limit, an increase in carnosine within their 
muscles will not improve their muscles buffering abilities.  On the contrary, a true placebo effect 
may occur to the elite population who are naïve about beta-alanine supplementation, believing it 
will improve their performance/capacity, therefore training harder, and subsequently improving 
performance/capacity. 
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Beta-alanine study 
Researcher:  Angus Lindsay 
Contact Details: Phone – 027 320 5373 
     Email – ajl103@student.canterbury.ac.nz 
 
Supervisors:  
- Bill Davison 
Contact Details: Phone – 364 2029 
     Email – bill.davison@canterbury.ac.nz 
 
- Nick Draper 
Contact Details: Phone – 364 2987 ext 4193 
     Email – nick.draper@canterbury.ac.nz 
 
- Steve Rickerby 
Contact Details: Phone – 364 2987 ext 8418 
     Email – Stephen.rickerby@canterbury.ac.nz 
 
Course: This study is a requirement of a Master’s degree in Biological Sciences 
Confidentiality: All data will be locked within the sports science lab of the University of 
Canterbury, offices of Bill Davison, Stephen Rickerby and Nick Draper, as well as password 
protected computers. 
Risks: There are no risks of participating in this study besides the physical demands of the testing 
themselves. 
Addresses: Angus Lindsay – University of Canterbury Sports Science Lab – University of 
Canterbury Recreation Centre, 22 Kirkwood Ave, Christchurch, New Zealand 
Purpose: The purpose of this study is to determine whether oral supplementation of beta-alanine 
affects aerobic and anaerobic capacity in elite cyclists. 
Introduction: Beta-alanine is an amino acid that is used in several medical fields for different 
purposes.  However, the purpose that will be focused on is its ability of it to form a dipeptide 
with another amino acid called histidine.  The combination of these two, of which beta-alanine is 
the rate limiting component, forms carnosine, which acts as the lactate buffer and what will be 
the focus of this study. 
Carnosine, which is located within the cells of the muscles, is able to absorb hydrogen ions from 
the breakdown of glucose via anaerobic gylcolysis.  Most of you will probably think that when 
you exercise at or near maximum, that when you get the burning sensation and fatigue sets in you 
can no longer perform at your best.  This is because of the production of lactic acid.  Forget what 
you’ve heard about lactic acid being harmful, because the body uses this lactic acid as fuel.   In 
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actual fact, it is the hydrogen ions, the by-product of lactate production, which causes this 
burning sensation.  So the science behind this burning sensation is what prevents your muscles 
functioning at their optimum, and to allow this to occur, the pH of your blood (which is 7.4 at 
neutral) has to remain at or around this number.  When the hydrogen ions are produced it 
decreases the pH of your blood and muscles to around 6.5 depending on how hard you are 
pushing, and it is this acidosis of your blood that causes the burning sensation and fatigue. 
Therefore, the proposed hypothesis of carnosine is that when these hydrogen ions are formed, 
rather than causing this acidosis, the carnosine absorbs the hydrogen ions, and allows your 
blood to remain at a neutral pH and subsequently your muscles can function at their optimum for 
longer. 
Previous research has found that oral supplementation of beta-alanine both improves aerobic and 
anaerobic capacity in athletic sprinters, middle distance runners and sedentary people in cycling.  
However, there is no definitive evidence on the effect it has on elite cyclists, and this is where 
using you as subjects will give definitive results in this area. 
So, the use of beta-alanine to produce carnosine will help improve you cycling performance in 
many ways.  Whether you are a sprinter or pursuiter, the use of this substance can help you 
overcome the fatigue effect of the hydrogen ions you produce when you cycle.   It’s quite often 
seen that when a sprinter tries to hold their maximum speed for a long duration, they will 
eventually fatigue.  Even as a pursuiter or road rider, you are always producing some hydrogen 
ions in a race, and when it comes down to a bunch sprint or the last 2 laps of a pursuit, the 
increased carnosine concentration in your muscle will help combat this.  For the road riders, in 
case you think it won’t have much of an effect, a recent study produced significant results 
indicating that supplementing on beta-alanine significantly increased sprinting performance in 
road cyclists after a simulated race. 
Therefore, when you supplement on beta-alanine, the level of carnosine within your muscles 
begins to increase over time.  Past research has indicated that 4 weeks can lead to an increase up 
to 50% above baseline levels and after 12 weeks up to 80%! 
Before the study: Before the study commences, classification has to be conducted to prove that 
you are indeed elite cyclists which is based on previous data.  It has widely been said that 
VO2max is the best predictor of aerobic performance.   Therefore, before any test is started, a 
VO2max test will be done a few days prior to the initial testing. 
Aerobic test: This will include a step test, whereby you bring in your own road bike and we set it 
up your specifications onto a velotron ergometer.  Therefore, we get better indicators of your 
capacity and better specificity.  The step test will include a 20 minute warm up (everyone has to 
do this) and then will commence at 100 watts.   Every 3 minutes, you have to increase your 
power output by 40 watts.  This 3 minute window allows your blood to settle and for the toxins 
you produce to plateau.  At the point where you increase your power, a small blood sample from 
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the tip of your finger will be taken to analyze the level of lactate in your blood.  This is done by 
giving you a small prick at the tip of your finger and then the blood is analyzed.  This will be 
done every 3 minutes.  Heart rate and lactate concentrations will be measured along the course of 
the test, and we will determine your final finishing power, and also your power (anaerobic 
threshold) when your blood lactate concentrations rise to 4mmol.L-1.  Therefore, it is essential 
that you push yourself to the limit as it will be these two indicators that will prove if you are 
indeed an elite aerobic cyclist. 
Anaerobic test: This test is more for the sprinters whose aerobic performance won’t be that of 
the aerobic athletes, however all endurance cyclists have to participate.  The test will include a 30 
second Wingate test to measure peak power, watts per kg, average power, work done, and fatigue 
index.  It is a very simple test where you cycle maximally for 30 seconds as all the necessary data 
is fed to a computer. 
These tests will be conducted within 5 days of each other.  Each person will be given a time and 
date to come in to the lab to perform these tests. 
Now after getting back many replies, most seem to be able to/or want to do the testing in the 
October-December group.  Because of this, the testing will have to be done in this period so that 
all cyclists are doing approximately the same sort of training.  If it were in April-June, training 
would have changed too dramatically and the results would vary on to big of a scale.  Therefore, 
it is up to the people who wished to do it in April to do the testing in October. 
The testing will be conducted at Canterbury University.  Therefore it will be up to you to make 
arrangements and a decision if you are able to make the testing on a specific day.   
Now it is very important that before you commence testing, that you have no performance 
enhancing substances in your system.  Therefore, no creatine can be taken a month before the 
testing, and if you are taking beta-alanine already, it is essential to stop supplementation 
immediately.  Protein shakes and vitamins etc. are fine to continue with.  Also, please try and 
avoid any caffeinated drinks 2 days prior to the testing. 
When each of you arrives to the do the classification testing, you will be asked to sign a 
declaration form giving your consent to allow me to perform these tests.  I need to state clearly, 
that once you have begun the study, you are able to withdraw from the study for any reason at 
anytime. 
What also is important in these tests, is that if indeed this product does have a significant effect, I 
need to be able to quantify the increased concentration of carnosine in the muscle.  This is to 
prove that it is the increased carnosine concentration that is having the effect and not the type of 
training that you are doing.  There are two ways that can accomplish this.  Firstly, there are 
muscle biopsies which I am NOT going to subject you to, and then there is the use of an MRI 
machine that is able to detect concentrations of the carnosine within your muscle.  Therefore, I 
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will be indicating a date that you will have to meet me at the hospital to undergo a short MRI test 
to quantify the level of carnosine in your muscles. 
 
The study: The study will involve an 8 week block of oral supplementation of beta-alanine.  
Depending upon how many subjects are involved, you will be split up randomly into two groups.  
A beta-alanine group and a placebo group.  Of course, you will be blinded as to which one you 
are on. I will also be blinded to this to give an unbiased results and it will be my supervisors who 
will randomly assign you to a group. 
Each group will come in and do both the aerobic and anaerobic tests on days within 5 days of 
each other, and then given a container of either of the substances and instructed to orally 
supplement on their substance for a given number of times per day for 8 weeks.  Following the 8 
weeks of oral supplementation, each of you will be instructed to go back to the lab that you had 
the classification and first testing conducted, and re-do the testing again. 
From here, I will analyze all of the data and write it up in a thesis and once complete, will report 
to all of you the findings and what sort of an impact beta-alanine has on elite cyclists both in 
aerobic and anaerobic capacity in a summary sheet. 
If I can also get you to fill in a rough training log for the 8 week period that you do during the 
study as the type of training might influence the results depending on what it is that you are 
doing. 
There will also be a slight time difference between the MRI test at the hospital and your second 
set of testing which will go over the 8 week period, but keep using the substance up until the tests 
are over. 
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Researcher:  Angus Lindsay 
Contact Details: Phone – 027 320 5373 
     Email – ajl103@student.canterbury.ac.nz 
 
Supervisors:  
- Bill Davison 
Contact Details: Phone – 364 2029 
     Email – bill.davison@canterbury.ac.nz 
 
- Nick Draper 
Contact Details: Phone – 364 2987 ext 4193 
     Email – nick.draper@canterbury.ac.nz 
 
- Steve Rickerby 
Contact Details: Phone – 364 2987 ext 8418 
     Email – Stephen.rickerby@canterbury.ac.nz 
Considerations 
While there have been a number of studies undertaken examining the effects of beta-alanine on sporting 
performance such testing for differences in power output on a cycle, changes in maximal oxygen uptake, and blood 
lactate concentrations, to date I have not found significant research examining the effects of beta-alanine on one 
kilometer time trial performance and seated 30 second Wingate tests. 
Due to the physical nature of the tests, all subjects will be required to complete a questionnaire prior to any 
testing that covers their medical history including any medication they may be on, current and/or past 
injuries/medical conditions, and any family history of medical conditions. In addition to this, the subjects will 
all have their blood pressure and resting heart rate taken and recorded to ensure they are physically suitable to 
take part. 
Finally, subjects will be informed of the College's complaints procedure if have any concerns regarding the study or 
researchers and wish to raise an issue. Also, the subject consent form will ensure that all subjects are willing to take 
part and confidentially of subjects data will be ensured. 
 
V02 Max Test Procedure 
You will be required to be at the University of Canterbury sport science laboratory at least 60 minutes prior to the 
start of the V02 Max test. This is to make sure there is adequate time to do preliminary tests on resting heart rate, 
blood lactate, and blood pressure levels, as well as an adequate warm-up of 30 minutes. 
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If results from the preliminary results are within acceptable ranges and you are willing to continue, you will be 
fitted with the necessary monitoring equipment such as heart rate monitor and CosMed K4B2 (this includes a small 
pack that will sit on your back and a face mask that will measure oxygen consumption) ready to begin the test. If the 
preliminary test results show anything of possible concern, you must gain written clearance from your GP to take 
part in further testing. 
The test will be completed on a king cycle beginning at a wattage that is reasonably comfortable and then 
increasing by 100Watts every 3 minutes until you choose to cease the test. At each 3 minute interval, blood lactate 
levels will be recorded using Accujet and Lactate Pro equipment. This involves a very small needle pricking the end 
of a finger, and is virtually painless. 
 
Following the completion of the test, you will complete a brief warm-down on the king cycle.  
For this test could you please adhere to the following guidelines: 
S   Try and keep as fresh as possible for the tests by refraining from vigorous training in the 48 hours 
prior to the testing. A period of complete rest from any training should be observed 12 hours prior to 
testing. 
•S   Normally a high carbohydrate diet, low in fat should be followed in the days leading up to testing. 
S   Refrain from tea, coffee, or any other caffeine containing beverages (coke, V, Lift Plus, Redbull, etc.) 
for 7 days leading up to the test. This is very important as consuming caffeine close to the time of 
testing may affect the results. 
S   Alcohol should be avoided for at least 12 hours prior to testing and no large meals should be eaten 3 
hours prior to testing. 
You may choose to bring a high carbohydrate snack or sports drink to consume on 
completion of both tests to aid recovery. 
 
Wingate Procedure 
You will be required to be at the University of Canterbury sport science laboratory at least 60 minutes prior to the 
start of the 30 second Wingate test. This is to make sure there is time for an adequate warm-up of 30 minutes. 
If results from the preliminary results found before the VO2 max test are within acceptable ranges and you are 
willing to continue, you will be fitted to the Wingate machine.  If the preliminary test results show anything of 
possible concern, you must gain written clearance from your GP to take part in further testing. 
The test will be completed on a Wingate cycle machine which gives accurate data output into a computer.  You 
will be asked to remain seated during the effort and go as hard as you can for the entire 30 seconds while getting 
verbal encouragement. 
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Ramp Test Procedure 
You will be required to be at the University of Canterbury sport science laboratory at least 60 minutes prior to the 
start of the ramp test. This is to make sure there is time for an adequate warm-up of 30 minutes. 
If results from the preliminary results found before the VO2 max test are within acceptable ranges and you are 
willing to continue, you will be fitted to the king cycle machine.  If the preliminary test results show anything of 
possible concern, you must gain written clearance from your GP to take part in further testing. 
The test will be completed on a king cycle  which gives accurate data output into a computer.  You will be asked 
to remain seated during the effort.  You will begin the test at 40W at a cadence which suits you.  Every 3 minutes 
you will be asked to increase the wattage by 40W.  At each 3 minute interval, blood lactate levels will be recorded 
using Accujet and Lactate Pro equipment. This involves a very small needle pricking the end of a finger, and is 
virtually painless. 
 
Risks of Maximal Exercise Testing 
With any type of vigorous exercise comes a remote chance of both injury and death. It is also logical to assume 
that such risks are increased when the exercise is pushed to maximal effort, particularly if the supervision of 
the subject is inadequate. Conversely the risks diminish perhaps to vanishing point, when full medical 
precautions are taken including things such as a pre-exercise questionnaire and preliminary testing (e.g. blood 
pressure and heart rate testing). 
With this in mind, there are several criteria that are used to stop any test immediately: 
• Chest pain 
• Severe dyspnoea (difficulty in breathing) 
• Noticeable changes in pallor 
• Cold moist skin 
• Cyanosis (skin turning blue) 
• Confusion of the subject 
• Stumbling-uncoordinated 
• Desire by subject to stop 
The information you divulge during pre-test screening and the actual test results will remain confidential between 
the testers and yourself and is necessary to determine any risks during testing.  In addition, you will be provided 
with a summary of your results and an interpretation of the data. 
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Researcher:  Angus Lindsay 
Contact Details: Phone – 027 320 5373 
     Email – ajl103@student.canterbury.ac.nz 
 
Supervisors:  
- Bill Davison 
Contact Details: Phone – 364 2029 
     Email – bill.davison@canterbury.ac.nz 
 
- Nick Draper 
Contact Details: Phone – 364 2987 ext 4193 
     Email – nick.draper@canterbury.ac.nz 
 
- Steve Rickerby 
Contact Details: Phone – 364 2987 ext 8418 
     Email – Stephen.rickerby@canterbury.ac.nz 
 
 
 
Informed Consent & Release of Liability for 
Participation in a Fitness Testing Programme 
 
 
 
1. Explanation of Testing Procedure 
 
I, the undersigned, consent to voluntarily participate in the fitness testing and 
fitness program at University of Canterbury.  I understand that I will be exercising 
from sub-maximal to maximum levels depending on the test certain data may be 
obtained (this could include; blood pressure, blood samples, oxygen and heart rate). 
All testing will be directed and monitored by a qualified trainer of University of 
Canterbury who will give me exact instructions of any activities to be conducted. 
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I have already informed University of Canterbury of any medical conditions or 
prescribed medications I am taking, and will inform University of Canterbury of 
any changes to these medical conditions or medications made by myself or my 
doctor prior to testing.   
 
 
 
2. Description of Potential Risks 
 
I understand and have been informed that my participation in fitness testing may 
have risks associated with the cardiorespiratory system that cannot always be 
predicted. These include, but are not limited to, abnormal changes to heart rate or 
blood pressure, ineffective functioning of the heart, and in very rare instances, heart 
attack, stroke or even death.  
 
I fully understand the risks that are associated with my testing programme 
including physical injury, heart attack, or in rare instance death, and knowing these 
risks I hereby indicate a desire to participate, and accept any and all risks of injury 
or death. 
 
3. Confidentiality 
 
I have been informed that any information pertaining to me obtained during the 
testing is confidential and will be kept on project leader’s personal computer in a 
locked office and will be held securely for two years and then destroyed. 
 
I have read the preceding information in its entirety and fully understand it.   
 
Any questions that have occurred to me regarding the procedures of this 
programme have been answered to my full satisfaction. 
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I understand that I can withdraw from the testing programme at any time without 
prejudice. 
 
I express full voluntary consent, release all liability and accept all risks associated 
with all services and procedures of University of Canterbury as explained herein. 
 
 
 
 Date: ...............................................................  
 
  
 Participant Signature: ....................................  
 
  
 University of Canterbury  
 Representative: ..............................................  
 
 
 
 
 
Pre-Exercise Medical/Health Evaluation 
 
 
In order for University of Canterbury to design you the safest and most effective 
exercise programme we need information regarding your health.  This information 
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is required purely for your personal safety, and remember that everything you 
record is strictly confidential. 
 
Name: _________________________________________________ Date: _________________________  
 
Are you taking any medication or drugs? 
 No 
 Yes:  Name of medication _____________________________________ 
              Reason for using medication _______________________________ 
               ______________________________________________________ 
               ______________________________________________________ 
              Dose__________________________________________________ 
 
Name and address of family GP: _________________________________ 
___________________________________________________________________
_______________________________________________________ 
 
Does your doctor know you are participating in this exercise program? 
 No 
 Yes 
 
Do you now, or have you had in the past: (tick) Yes     No 
1. Asthma 
2. History of heart problems, chest pain or stroke.  __   ___ 
3. Increased blood pressure.  __   ___ 
4. Any chronic illness or condition.  __   ___ 
5. Difficulty with physical exercise.  __   ___ 
6. Advice from a physician not to exercise.  __   ___ 
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7. Recent surgery (last 12 months). 
 
 
 
  __   ___ 
8. Pregnancy (now or within last 3 months).  __   ___ 
9. History of breathing or lung problems.  __   ___ 
 
 
10. Muscle, joint, or back disorder, or any other previous  
                                       injury still affecting you.  __   ___ 
11.Diabetes or thyroid condition.  __   ___ 
12.Cigarette smoking habit.  __   ___ 
  __   
13.Increased blood cholesterol.  __   ___ 
14.History of heart problems in immediate family.  __   ___ 
15.Hernia or any condition that may be aggravated by  
 lifting weights. ___   ___ 
16.Do you have any other medical/health condition not  
 detailed above. ___   ___ 
 
If you answer yes to any of the pre-exercise medical questions you may need to be 
excluded from the study.  The tester will discuss with you the risks associated with 
your condition and make a decision based upon this discussion.  This decision will 
be based upon the tester’s assessment of the additional potential health risks 
associated with your condition.  Additionally, if you answer yes to questions 2, 6, 
8, 10, or 15 you would automatically have to be excluded from the study. 
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Please give details below of any of the questions above to which you answered yes: 
 _____________________________________________________________  
 _____________________________________________________________  
 _____________________________________________________________  
 _____________________________________________________________  
 _____________________________________________________________  
 _____________________________________________________________  
 _____________________________________________________________  
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Angus Lindsay 
School of Biological Sciences 
University of Canterbury 
Private Bag 4800 
Christchurch 
8140 
 
October 1st 2009 
 
CONSENT FORM 
 
The effect of beta-alanine supplementation on aerobic and anaerobic capacity in trained 
cyclists. 
 
 
I have read and understood the description of the above-named project. On this basis I agree to 
participate as a subject in the project, and I consent to publication of the results of the project 
with the understanding that anonymity will be preserved.  
 
 
I understand that comments I make may be written down and used in the report discussion. 
 
 
I understand that my name will not be written down next to my comments and that my name will 
not be used in any part of the results, data, and final report.  
 
 
I understand also that I may at any time withdraw from the project, including withdrawal of any 
information I have provided.  
 
I understand that my participation is part of the required field toward a Master’s Degree. 
 
 
I note that the project has been reviewed and approved by the University of Canterbury Human 
Ethics Committee.  
 
 
NAME (please print): …………………………………………………………….  
 
Signature:  
 
Date: 
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Researcher:  Angus Lindsay 
Contact Details: Phone – 027 320 5373 
     Email – ajl103@student.canterbury.ac.nz 
 
Supervisors:  
- Bill Davison 
Contact Details: Phone – 364 2029 
     Email – bill.davison@canterbury.ac.nz 
 
- Nick Draper 
Contact Details: Phone – 364 2987 ext 4193 
     Email – nick.draper@canterbury.ac.nz 
 
- Steve Rickerby 
Contact Details: Phone – 364 2987 ext 8418 
     Email – Stephen.rickerby@canterbury.ac.nz 
 
